Exact Mass: 287.1092

Exact Mass Matches: 287.1092

Found 500 metabolites which its exact mass value is equals to given mass value 287.1092, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Rutaecarpine

3,13,21-triazapentacyclo[11.8.0.0^{2,10}.0^{4,9}.0^{15,20}]henicosa-1(21),2(10),4(9),5,7,15(20),16,18-octaen-14-one

C18H13N3O (287.1059)


Rutecarpine is a member of beta-carbolines. Rutaecarpine is a natural product found in Bouchardatia neurococca, Zanthoxylum dimorphophyllum, and other organisms with data available. Rutaecarpine belongs to the family of Pyridopyrimidines. These are compounds containing a pyridopyrimidine, which consists of a pyridine fused to a pyrimidine. D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents Rutaecarpine, an alkaloid of Evodia rutaecarpa, is an inhibitor of COX-2 with an IC50 value of 0.28 μM. Rutaecarpine, an alkaloid of Evodia rutaecarpa, is an inhibitor of COX-2 with an IC50 value of 0.28 μM.

   

Lycorine

1H-[1,3]Dioxolo[4,5-j]pyrrolo[3,2,1-de]phenanthridine-1,2-diol, 2,4,5,7,12b,12c-hexahydro-, (1S,2S,12bS,12cS)-

C16H17NO4 (287.1158)


Lycorine is an indolizidine alkaloid that is 3,12-didehydrogalanthan substituted by hydroxy groups at positions and 2 and a methylenedioxy group across positions 9 and 10. Isolated from Crinum asiaticum, it has been shown to exhibit antimalarial activity. It has a role as a protein synthesis inhibitor, an antimalarial, a plant metabolite and an anticoronaviral agent. It derives from a hydride of a galanthan. Lycorine is a natural product found in Sternbergia clusiana, Pancratium trianthum, and other organisms with data available. Lycorine is a toxic crystalline alkaloid found in various Amaryllidaceae species, such as the cultivated bush lily (Clivia miniata), surprise lilies (Lycoris), and daffodils (Narcissus). It may be highly poisonous, or even lethal, when ingested in certain quantities. Symptoms of lycorine toxicity are vomiting, diarrhea, and convulsions. Lycorine, definition at mercksource.com Regardless, it is sometimes used medicinally, a reason why some groups may harvest the very popular Clivia miniata. An indolizidine alkaloid that is 3,12-didehydrogalanthan substituted by hydroxy groups at positions and 2 and a methylenedioxy group across positions 9 and 10. Isolated from Crinum asiaticum, it has been shown to exhibit antimalarial activity. relative retention time with respect to 9-anthracene Carboxylic Acid is 0.144 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.136 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.138 CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 2316 INTERNAL_ID 2316; CONFIDENCE Reference Standard (Level 1) [Raw Data] CBA60_Lycorine_pos_30eV.txt [Raw Data] CBA60_Lycorine_pos_10eV.txt [Raw Data] CBA60_Lycorine_pos_50eV.txt [Raw Data] CBA60_Lycorine_pos_40eV.txt [Raw Data] CBA60_Lycorine_pos_20eV.txt Lycorine is a natural alkaloid extracted from the Amaryllidaceae plant. Lycorine is a potent and orally active SCAP inhibitor with a Kd value 15.24 nM. Lycorine downregulates the SCAP protein level without changing its transcription[2]. Lycorine is also a melanoma vasculogenic inhibitor[3]. Lycorine can be used for the study of prostate cancer and metabolic diseases[2].
Lycorine is a natural alkaloid extracted from the Amaryllidaceae plant. Lycorine is a potent and orally active SCAP inhibitor with a Kd value 15.24 nM. Lycorine downregulates the SCAP protein level without changing its transcription[2]. Lycorine is also a melanoma vasculogenic inhibitor[3]. Lycorine can be used for the study of prostate cancer and metabolic diseases[2].
Lycorine is a natural alkaloid extracted from the Amaryllidaceae plant. Lycorine is a potent and orally active SCAP inhibitor with a Kd value 15.24 nM. Lycorine downregulates the SCAP protein level without changing its transcription[2]. Lycorine is also a melanoma vasculogenic inhibitor[3]. Lycorine can be used for the study of prostate cancer and metabolic diseases[2].

   

Galantamine

(1S,12S,14R)-9-methoxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.01,12.06,17]heptadeca-6(17),7,9,15-tetraen-14-ol

C17H21NO3 (287.1521)


Galanthamine is a benzazepine alkaloid isolated from certain species of daffodils. It has a role as an antidote to curare poisoning, an EC 3.1.1.7 (acetylcholinesterase) inhibitor, a cholinergic drug, an EC 3.1.1.8 (cholinesterase) inhibitor and a plant metabolite. It is an organic heterotetracyclic compound, a tertiary amino compound, a benzazepine alkaloid and a benzazepine alkaloid fundamental parent. It is a conjugate base of a galanthamine(1+). Galantamine is a tertiary alkaloid and reversible, competitive inhibitor of the acetylcholinesterase (AChE) enzyme, which is a widely studied therapeutic target used in the treatment of Alzheimers disease. First characterized in the early 1950s, galantamine is a tertiary alkaloid that was extracted from botanical sources, such as Galanthus nivalis. Galantamine was first studied in paralytic and neuropathic conditions, such as myopathies and postpolio paralytic conditions, and for reversal of neuromuscular blockade. Following the discovery of its AChE-inhibiting properties, the cognitive effects of galantamine were studied in a wide variety of psychiatric disorders such as mild cognitive impairment, cognitive impairment in schizophrenia and bipolar disorder, and autism; however, re-development of the drug for Alzheimer’s disease did not commence until the early 1990s due to difficulties in extraction and synthesis. Galantamine blocks the breakdown of acetylcholine in the synaptic cleft, thereby increasing acetylcholine neurotransmission. It also acts as an allosteric modulator of the nicotinic receptor, giving its dual mechanism of action clinical significance. The drug was approved by the FDA in 2001 for the treatment of mild to moderate dementia of the Alzheimers type. As Alzheimers disease is a progressive neurodegenerative disorder, galantamine is not known to alter the course of the underlying dementing process. Galantamine works to block the enzyme responsible for the breakdown of acetylcholine in the synaptic cleft, thereby enhancing cholinergic neuron function and signalling. Under this hypothesized mechanism of action, the therapeutic effects of galantamine may decrease as the disease progression advances and fewer cholinergic neurons remain functionally intact. It is therefore not considered to be a disease-modifying drug. Galantamine is marketed under the brand name Razadyne, and is available as oral immediate- and extended-release tablets and solution. Galantamine is a Cholinesterase Inhibitor. The mechanism of action of galantamine is as a Cholinesterase Inhibitor. Galantamine is an oral acetylcholinesterase inhibitor used for therapy of Alzheimer disease. Galantamine is associated with a minimal rate of serum enzyme elevations during therapy and has not been implicated as a cause of clinically apparent liver injury. Galantamine is a natural product found in Pancratium trianthum, Lycoris sanguinea, and other organisms with data available. A benzazepine derived from norbelladine. It is found in GALANTHUS and other AMARYLLIDACEAE. It is a cholinesterase inhibitor that has been used to reverse the muscular effects of GALLAMINE TRIETHIODIDE and TUBOCURARINE and has been studied as a treatment for ALZHEIMER DISEASE and other central nervous system disorders. See also: Galantamine Hydrobromide (active moiety of). A benzazepine derived from norbelladine. It is found in galanthus and other amaryllidaceae. Galantamine is a cholinesterase inhibitor that has been used to reverse the muscular effects of gallamine triethiodide and tubocurarine, and has been studied as a treatment for Alzheimers disease and other central nervous system disorders. [PubChem] D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010277 - Parasympathomimetics D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D002800 - Cholinesterase Inhibitors N - Nervous system > N06 - Psychoanaleptics > N06D - Anti-dementia drugs > N06DA - Anticholinesterases D002491 - Central Nervous System Agents > D018697 - Nootropic Agents A benzazepine alkaloid isolated from certain species of daffodils. C471 - Enzyme Inhibitor > C47792 - Acetylcholinesterase Inhibitor D004791 - Enzyme Inhibitors Galanthamine is a potent acetylcholinesterase (AChE) inhibitor with an IC50 of 500 nM. Galanthamine is a potent acetylcholinesterase (AChE) inhibitor with an IC50 of 500 nM.

   

Mesembrenone

6H-Indol-6-one, 3a-(3,4-dimethoxyphenyl)-1,2,3,3a,7,7a-hexahydro-1-methyl-, (3aR-cis)-

C17H21NO3 (287.1521)


Mesembrenone is a member of pyrrolidines. Mesembrenone is a natural product found in Bergeranthus scapiger, Oscularia deltoides, and other organisms with data available.

   

Etodolac

(1,8-Diethyl-1,3,4,9-tetrahydro-pyrano[3,4-b]indol-1-yl)-acetic acid

C17H21NO3 (287.1521)


Etodolac is only found in individuals that have used or taken this drug. It is a non-steroidal anti-inflammatory drug (NSAID) with anti-inflammatory, analgesic and antipyretic properties. Its therapeutic effects are due to its ability to inhibit prostaglandin synthesis. It is indicated for relief of signs and symptoms of rheumatoid arthritis and osteoarthritis. Similar to other NSAIDs, the anti-inflammatory effects of etodolac result from inhibition of the enzyme cycooxygenase (COX). This decreases the synthesis of peripheral prostaglandins involved in mediating inflammation. Etodolac binds to the upper portion of the COX enzyme active site and prevents its substrate, arachidonic acid, from entering the active site. Etodolac was previously thought to be a non-selective COX inhibitor, but it is now known to be 5 – 50 times more selective for COX-2 than COX-1. Antipyresis may occur by central action on the hypothalamus, resulting in peripheral dilation, increased cutaneous blood flow, and subsequent heat loss. M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids > M01AB - Acetic acid derivatives and related substances D018501 - Antirheumatic Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D016861 - Cyclooxygenase Inhibitors D004791 - Enzyme Inhibitors > D016861 - Cyclooxygenase Inhibitors > D052246 - Cyclooxygenase 2 Inhibitors C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D006133 - Growth Substances > D010937 - Plant Growth Regulators > D007210 - Indoleacetic Acids D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents KEIO_ID E034; [MS2] KO008956 KEIO_ID E034

   

Dihydromorphine

(1S,5R,13R,14S,17R)-4-methyl-12-oxa-4-azapentacyclo[9.6.1.0^{1,13}.0^{5,17}.0^{7,18}]octadeca-7(18),8,10-triene-10,14-diol

C17H21NO3 (287.1521)


Dihydromorphine is a metabolite of Hydromorphone. Dihydromorphine is a semi-synthetic opioid structurally related to and derived from morphine. The 7,8-double bond in morphine is reduced to a single bond to get dihydromorphine. (Wikipedia) D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics

   

Tenofovir

({[(2R)-1-(6-amino-9H-purin-9-yl)propan-2-yl]oxy}methyl)phosphonic acid

C9H14N5O4P (287.0783)


Tenofovir is only found in individuals that have used or taken this drug. Tenofovir, marketed by Gilead Sciences under the trade name Viread®, belongs to a class of antiretroviral drugs known as nucleotide analogue reverse transcriptase inhibitors (nRTIs), which block reverse transcriptase, an enzyme crucial to viral production in HIV-infected people. [Wikipedia]Tenofovir inhibits the activity of HIV reverse transcriptase by competing with the natural substrate deoxyadenosine 5’-triphosphate and, after incorporation into DNA, by DNA chain termination. Specifically, the drugs are analogues of the naturally occurring deoxynucleotides needed to synthesize the viral DNA and they compete with the natural deoxynucleotides for incorporation into the growing viral DNA chain. However, unlike the natural deoxynucleotides substrates, NRTIs and NtRTIs (nucleoside/tide reverse transcriptase inhibitors) lack a 3-hydroxyl group on the deoxyribose moiety. As a result, following incorporation of an NRTI or an NtRTI, the next incoming deoxynucleotide cannot form the next 5-3 phosphodiester bond needed to extend the DNA chain. Thus, when an NRTI or NtRTI is incorporated, viral DNA synthesis is halted, a process known as chain termination. All NRTIs and NtRTIs are classified as competitive substrate inhibitors. C471 - Enzyme Inhibitor > C1589 - Reverse Transcriptase Inhibitor > C97452 - Nucleoside Reverse Transcriptase Inhibitor D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D018894 - Reverse Transcriptase Inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D004791 - Enzyme Inhibitors > D019384 - Nucleic Acid Synthesis Inhibitors C254 - Anti-Infective Agent > C281 - Antiviral Agent Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Tenofovir (GS 1278) is a nucleotide reverse transcriptase inhibitor to treat HIV and chronic Hepatitis B (HBV)[1].

   

Ritodrine

4-(2-{[(1R,2S)-1-hydroxy-1-(4-hydroxyphenyl)propan-2-yl]amino}ethyl)phenol

C17H21NO3 (287.1521)


Ritodrine is only found in individuals that have used or taken this drug. It is an adrenergic beta-agonist used to control premature labor. [PubChem]Ritodrine is beta-2 adrenergic agonist. It binds to beta-2 adrenergic receptors on outer membrane of myometrial cell, activates adenyl cyclase to increase the level of cAMP which decreases intracellular calcium and leads to a decrease of uterine contractions. G - Genito urinary system and sex hormones > G02 - Other gynecologicals > G02C - Other gynecologicals > G02CA - Sympathomimetics, labour repressants D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013566 - Sympathomimetics D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D012102 - Reproductive Control Agents > D015149 - Tocolytic Agents

   

Norlaudanosoline

(1S)-1-[(3,4-dihydroxyphenyl)methyl]-1,2,3,4-tetrahydroisoquinoline-6,7-diol

C16H17NO4 (287.1158)


Norlaudanosoline (CAS: 4747-99-3), also known as tetrahydropapaveroline, belongs to the class of organic compounds known as benzylisoquinolines. These are organic compounds containing an isoquinoline to which a benzyl group is attached. Norlaudanosoline is a very strong basic compound (based on its pKa). Norlaundanosoline is a key intermediate in the synthesis of the benzylisoquinoline alkaloids, providing the upper isoquinoline portion of the morphinan skeleton. It is involved in alkaloid biosynthesis and is synthesized by the enzyme (S)-norlaudanosoline synthase. Formerly believed to be a biosynthetic precursor of morphine in Papaver somniferum, now disproved

   

Tetraphyllin B

4-hydroxy-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}cyclopent-2-ene-1-carbonitrile

C12H17NO7 (287.1005)


Tetraphyllin B is found in papaya. Tetraphyllin B is isolated from dried damiana leaves (Turnera diffusa Isolated from dried damiana leaves (Turnera diffusa). Tetraphyllin B is found in papaya.

   

Hippagine

3alpha-Pancracine

C16H17NO4 (287.1158)


   

3-Demethoxypiplartine

3-Demethoxypiplartine

C16H17NO4 (287.1158)


   

NAc-AAA-ME

Methyl-N-acetyl-N-L-alanyl-N-L-alanyl alaninate

C12H21N3O5 (287.1481)


   

Hamayne

Vittatine, 11-hydroxy-

C16H17NO4 (287.1158)


   
   
   

Sulmazole

2-[2-Methoxy-4-(methylsulphinyl)phenyl]-3H-imidazo[4,5-b]pyridine

C14H13N3O2S (287.0728)


C78274 - Agent Affecting Cardiovascular System > C78322 - Cardiotonic Agent D004791 - Enzyme Inhibitors > D010726 - Phosphodiesterase Inhibitors D020011 - Protective Agents > D002316 - Cardiotonic Agents D002317 - Cardiovascular Agents

   

Gabazine

6-Amino-5-methyl-3-(4-methoxyphenyl)-1-pyridaziniumbutyric acid, bromide

C15H17N3O3 (287.127)


D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018756 - GABA Antagonists

   

Clavamycin E

Antibiotic CA 146B

C11H17N3O6 (287.1117)


   

norlaudanosoline

Tetrahydropapaveroline

C16H17NO4 (287.1158)


Origin: Animal; SubCategory_DNP: Isoquinoline alkaloids, Benzylisoquinoline alkaloids relative retention time with respect to 9-anthracene Carboxylic Acid is 0.055 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.054 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.053 Acquisition and generation of the data is financially supported by the Max-Planck-Society IPB_RECORD: 2522; CONFIDENCE confident structure

   

Cycloguanil Hydrochloride

Cycloguanil Hydrochloride

C11H15Cl2N5 (287.0704)


D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents D004791 - Enzyme Inhibitors > D005493 - Folic Acid Antagonists D007004 - Hypoglycemic Agents > D001645 - Biguanides

   

(R)-Norlaudanosoline

(R)-Norlaudanosoline

C16H17NO4 (287.1158)


   

CID 443694

11-Hydroxyvittatine

C16H17NO4 (287.1158)


   
   

3-O-Methyltolcapone

3-O-Methyl Tolcapone

C15H13NO5 (287.0794)


   

Nodinitib-1

ML130 (Nodinitib-1)

C14H13N3O2S (287.0728)


   

noroxymorphone

(1S,5R,13R,17S)-10,17-dihydroxy-12-oxa-4-azapentacyclo[9.6.1.0¹,¹³.0⁵,¹⁷.0⁷,¹⁸]octadeca-7(18),8,10-trien-14-one

C16H17NO4 (287.1158)


noroxymorphone is a metabolite of oxymorphone. Oxymorphone (Opana, Numorphan, Numorphone) or 14-Hydroxydihydromorphinone is a powerful semi-synthetic opioid analgesic first developed in Germany in 1914, patented in the USA by Endo Pharmaceuticals in 1955 and introduced to the United States market in January 1959 and other countries around the same time. It (along with hydromorphone) was designed to have less incidence of side effects than morphine and heroin. (Wikipedia) D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist

   

Piperanine

(2E)-5-(2H-1,3-benzodioxol-5-yl)-1-(piperidin-1-yl)pent-2-en-1-one

C17H21NO3 (287.1521)


Isolated from pepper. Piperanine is found in herbs and spices and pepper (spice). Piperanine is found in herbs and spices. Piperanine is isolated from pepper.

   

Feruperine

(2E,4Z)-5-(4-hydroxy-3-methoxyphenyl)-1-(piperidin-1-yl)penta-2,4-dien-1-one

C17H21NO3 (287.1521)


Alkaloid from pepper (Piper nigrum) (Piperaceae). Feruperine is found in herbs and spices and pepper (spice). Feruperine is found in herbs and spices. Feruperine is an alkaloid from pepper (Piper nigrum) (Piperaceae).

   

Pipermethystine

6-oxo-1-(3-Phenylpropanoyl)-1,2,3,6-tetrahydropyridin-3-yl acetic acid

C16H17NO4 (287.1158)


Pipermethystine is found in beverages. Pipermethystine is an alkaloid from the leaves of kava (Piper methysticum). FDA advises against use of kava in food due to potential risk of severe liver damage (2002) Pipermethystine is an alkaloid present in the aerial (aboveground) portions of the kava plant. Alkaloid from the leaves of kava (Piper methysticum). FDA advises against use of kava in food due to potential risk of severe liver damage (2002)

   

Citrusinine II

1,3,5-trihydroxy-4-methoxy-10-methyl-9,10-dihydroacridin-9-one

C15H13NO5 (287.0794)


Alkaloid from the root bark of Citrus sinensis variety brasiliensis (navel orange). Citrusinine II is found in sweet orange and citrus. Citrusinine II is found in citrus. Citrusinine II is an alkaloid from the root bark of Citrus sinensis var. brasiliensis (navel orange

   

Grandisine III

1,3,6-trihydroxy-5-methoxy-10-methyl-9,10-dihydroacridin-9-one

C15H13NO5 (287.0794)


Grandisine III is found in citrus. Grandisine III is an alkaloid from roots of several hybrid seedlings resulting from a cross of Pummelo (Citrus grandis cv. May Pummelo x Marsh grapefruit (Citrus paradisi)) (Rutaceae). Alkaloid from roots of several hybrid seedlings resulting from a cross of Pummelo (Citrus grandis cv. May Pummelo x Marsh grapefruit (Citrus paradisi)) (Rutaceae). Grandisine III is found in citrus.

   

N-Ribosylhistidine

(2S)-2-amino-3-{1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-imidazol-4-yl}propanoic acid

C11H17N3O6 (287.1117)


N tau-ribosylhistidine (His-R) is a histidine derivative found in the urine of histidinemic patients (histidinemia is an autosomal recessive metabolic disorder characterized by increased levels of histidine in blood, urine, and cerebrospinal fluid). The enzymes responsible for the formation of His-R are NAD (P) + nucleosidase [EC 3.2.2.5], nucleotide pyrophosphatase [EC 3.5.1.9] and 5-nucleotidase [EC 3.1.3.5]. (PMID: 2992472) [HMDB] N tau-ribosylhistidine (His-R) is a histidine derivative found in the urine of histidinemic patients (histidinemia is an autosomal recessive metabolic disorder characterized by increased levels of histidine in blood, urine, and cerebrospinal fluid). The enzymes responsible for the formation of His-R are NAD (P) + nucleosidase [EC 3.2.2.5], nucleotide pyrophosphatase [EC 3.5.1.9] and 5-nucleotidase [EC 3.1.3.5] (PMID: 2992472).

   

Clitocine

2-[(6-amino-5-nitropyrimidin-4-yl)amino]-5-(hydroxymethyl)oxolane-3,4-diol

C9H13N5O6 (287.0866)


Nucleoside isolated from the mushroom Clitocybe inversa (edibility unknown). Clitocine is found in mushrooms. Clitocine is found in mushrooms. Nucleoside isolated from the mushroom Clitocybe inversa (edibility unknown Clitocine, an adenosine nucleoside analog isolated from mushroom, is a potent and efficacious readthrough agent. Clitocine acts as a suppressor of nonsense mutations and can induce the production of p53 protein in cells harboring p53 nonsense-mutated alleles. Clitocine can induce apoptosis in multidrug-resistant human cancer cells by targeting Mcl-1. Anticancer activity[1][2]. Clitocine, an adenosine nucleoside analog isolated from mushroom, is a potent and efficacious readthrough agent. Clitocine acts as a suppressor of nonsense mutations and can induce the production of p53 protein in cells harboring p53 nonsense-mutated alleles. Clitocine can induce apoptosis in multidrug-resistant human cancer cells by targeting Mcl-1. Anticancer activity[1][2].

   

Nordihydrocodeine

(1S,5R,14S)-10-methoxy-12-oxa-4-azapentacyclo[9.6.1.0¹,¹³.0⁵,¹⁷.0⁷,¹⁸]octadeca-7(18),8,10-trien-14-ol

C17H21NO3 (287.1521)


Nordihydrocodeine belongs to the family of Morphinans. These are polycyclic compounds with a four-ring skeleton with three condensed six-member rings forming a partially hydrogenated phenanthrene moiety, one of which is aromatic while the two others are alicyclic.

   

6alpha-Hydroxy-hydromorphone

(14S)-4-methyl-12-oxa-4-azapentacyclo[9.6.1.0¹,¹³.0⁵,¹⁷.0⁷,¹⁸]octadeca-7(18),8,10-triene-10,14-diol

C17H21NO3 (287.1521)


6alpha-Hydroxy-hydromorphone is a metabolite of hydromorphone. Hydromorphone, a more common synonym for dihydromorphinone, commonly a hydrochloride (brand names Palladone, Dilaudid, and numerous others) is a very potent centrally acting analgesic drug of the opioid class. It is a derivative of morphine, to be specific, a hydrogenated ketone thereof and, therefore, a semi-synthetic drug. It is, in medical terms, an opioid analgesic and, in legal terms, a narcotic. (Wikipedia)

   

6beta-Hydroxy-hydromorphone

(14R)-4-methyl-12-oxa-4-azapentacyclo[9.6.1.0¹,¹³.0⁵,¹⁷.0⁷,¹⁸]octadeca-7(18),8,10-triene-10,14-diol

C17H21NO3 (287.1521)


6beta-Hydroxy-hydromorphone is a metabolite of hydromorphone. Hydromorphone, a more common synonym for dihydromorphinone, commonly a hydrochloride (brand names Palladone, Dilaudid, and numerous others) is a very potent centrally acting analgesic drug of the opioid class. It is a derivative of morphine, to be specific, a hydrogenated ketone thereof and, therefore, a semi-synthetic drug. It is, in medical terms, an opioid analgesic and, in legal terms, a narcotic. (Wikipedia)

   

Dihydroisomorphine

(1S,5R,13R,14R,17R)-4-methyl-12-oxa-4-azapentacyclo[9.6.1.0^{1,13}.0^{5,17}.0^{7,18}]octadeca-7,9,11(18)-triene-10,14-diol

C17H21NO3 (287.1521)


Dihydroisomorphine is a metabolite of hydromorphone. Hydromorphone, a more common synonym for dihydromorphinone, commonly a hydrochloride (brand names Palladone, Dilaudid, and numerous others) is a very potent centrally acting analgesic drug of the opioid class. It is a derivative of morphine, to be specific, a hydrogenated ketone thereof and, therefore, a semi-synthetic drug. It is, in medical terms, an opioid analgesic and, in legal terms, a narcotic. (Wikipedia)

   

(2E)-Hexenedioylcarnitine

3-{[(2E)-5-carboxypent-2-enoyl]oxy}-4-(trimethylammonio)butanoic acid

C13H21NO6 (287.1369)


(2E)-Hexenedioylcarnitine is an acylcarnitine. More specifically, it is an (2E)-hexenedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (2E)-Hexenedioylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine (2E)-Hexenedioylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

(2E)-3-Methylpent-2-enedioylcarnitine

3-[(4-carboxy-3-methylbut-2-enoyl)oxy]-4-(trimethylazaniumyl)butanoate

C13H21NO6 (287.1369)


(2E)-3-methylpent-2-enedioylcarnitine is an acylcarnitine. More specifically, it is an (2E)-3-methylpent-2-enedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (2E)-3-methylpent-2-enedioylcarnitine is therefore classified as a short chain AC. As a short-chain acylcarnitine (2E)-3-methylpent-2-enedioylcarnitine is a member of the most abundant group of carnitines in the body, comprising more than 50\\% of all acylcarnitines quantified in tissues and biofluids (PMID: 31920980). Some short-chain carnitines have been studied as supplements or treatments for a number of diseases, including neurological disorders and inborn errors of metabolism. In particular (2E)-3-methylpent-2-enedioylcarnitine is elevated in the blood or plasma of individuals with 3-hydroxy-3-methylglutarylCoA lyase deficiency (PMID: 32685354). (2E)-3-methylpent-2-enedioylcarnitine is elevated in the urine of individuals with 3-methylglutaconic aciduria (PMID: 7850987). Carnitine acetyltransferase (CrAT, EC:2.3.1.7) is responsible for the synthesis of all short-chain and short branched-chain acylcarnitines (PMID: 23485643). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

Hex-3-enedioylcarnitine

3-[(5-carboxypent-3-enoyl)oxy]-4-(trimethylazaniumyl)butanoate

C13H21NO6 (287.1369)


hex-3-enedioylcarnitine is an acylcarnitine. More specifically, it is an hex-3-enedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. hex-3-enedioylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine hex-3-enedioylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

(E)-3-(4-Chlorophenyl)-N-(4-methoxyphenyl)prop-2-enamide

(E)-3-(4-Chlorophenyl)-N-(4-methoxyphenyl)prop-2-enamide

C16H14ClNO2 (287.0713)


   

3-O-Methyltolcapone

2-methoxy-4-(4-methylbenzoyl)-6-nitrophenol

C15H13NO5 (287.0794)


   

Ritodrina

4-(1-hydroxy-2-{[2-(4-hydroxyphenyl)ethyl]amino}propyl)phenol

C17H21NO3 (287.1521)


G - Genito urinary system and sex hormones > G02 - Other gynecologicals > G02C - Other gynecologicals > G02CA - Sympathomimetics, labour repressants D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013566 - Sympathomimetics D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D012102 - Reproductive Control Agents > D015149 - Tocolytic Agents

   

1-[Amino-(3,4-dichloroanilino)methylidene]-2-propan-2-ylguanidine

1-[N-(3,4-dichlorophenyl)carbamimidamido]-N-(propan-2-yl)methanimidamide

C11H15Cl2N5 (287.0704)


D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent D007004 - Hypoglycemic Agents > D001645 - Biguanides

   

6-Chloro-2',3'-dideoxyguanosine

2-amino-6-chloro-9-[5-(hydroxymethyl)oxolan-2-yl]-6,9-dihydro-3H-purin-6-ol

C10H14ClN5O3 (287.0785)


   

9-(2-Phosphonomethoxypropyl)adenine

({[1-(6-amino-9H-purin-9-yl)propan-2-yl]oxy}methyl)phosphonic acid

C9H14N5O4P (287.0783)


D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D018894 - Reverse Transcriptase Inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents D004791 - Enzyme Inhibitors > D019384 - Nucleic Acid Synthesis Inhibitors

   

Hydromorphine

4-methyl-12-oxa-4-azapentacyclo[9.6.1.0^{1,13}.0^{5,17}.0^{7,18}]octadeca-7(18),8,10-triene-10,14-diol

C17H21NO3 (287.1521)


D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics

   

Incadronic acid

Hydronium (cycloheptylammonio)methylene-1,1-bisphosphonate

C8H19NO6P2 (287.0688)


C78281 - Agent Affecting Musculoskeletal System > C67439 - Bone Resorption Inhibitor D050071 - Bone Density Conservation Agents > D004164 - Diphosphonates

   

Isomazole

2-((2-Methoxy-4-methylsulfinyl)phenyl)-H-imidazo(4,5-b)pyridine

C14H13N3O2S (287.0728)


C78274 - Agent Affecting Cardiovascular System > C78322 - Cardiotonic Agent D004791 - Enzyme Inhibitors > D010726 - Phosphodiesterase Inhibitors D020011 - Protective Agents > D002316 - Cardiotonic Agents D002317 - Cardiovascular Agents

   

lycorine

5,7-dioxa-12-azapentacyclo[10.6.1.0²,¹⁰.0⁴,⁸.0¹⁵,¹⁹]nonadeca-2,4(8),9,15-tetraene-17,18-diol

C16H17NO4 (287.1158)


   

Epigalanthamin

9-methoxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.0¹,¹².0⁶,¹⁷]heptadeca-6,8,10(17),15-tetraen-14-ol

C17H21NO3 (287.1521)


D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010277 - Parasympathomimetics D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D002800 - Cholinesterase Inhibitors D002491 - Central Nervous System Agents > D018697 - Nootropic Agents D004791 - Enzyme Inhibitors

   

RepSox

2-[5-(6-methylpyridin-2-yl)-1H-pyrazol-4-yl]-1,5-naphthyridine

C17H13N5 (287.1171)


   

Riparin III

2,6-Dihydroxy-N-[2-(4-methoxyphenyl)ethyl]benzene-1-carboximidate

C16H17NO4 (287.1158)


   

N-(3-Methoxyphenyl)-4-chlorocinnamanilide

3-(4-Chlorophenyl)-N-(3-methoxyphenyl)prop-2-enimidate

C16H14ClNO2 (287.0713)


   

7-Chloro-3-methyl-1-phenyl-1,2,4,5-tetrahydro-3-benzazepin-8-ol

R-(+)-8-Chloro-2,3,4,5-tetrahydro-3-methyl-5-phenyl-1H-3- benzazepine-7-ol

C17H18ClNO (287.1077)


   

Thesinine

(Hexahydro-1H-pyrrolizin-1-yl)methyl (2E)-3-(4-hydroxyphenyl)prop-2-enoic acid

C17H21NO3 (287.1521)


Thesinine is a member of the class of compounds known as coumaric acid esters. Coumaric acid esters are aromatic compounds containing an ester derivative of coumaric acid. Thesinine is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Thesinine can be found in borage, which makes thesinine a potential biomarker for the consumption of this food product. Thesinine is a pyrrolizidine alkaloid first isolated from Thesium minkwitzianum from which it derives its name. It is also found in the flowers and seeds of borage .

   

indole-3-acetyl-isoleucine

N-(1-Carboxy-2-methylbutyl)-2-(1H-indol-3-yl)ethanecarboximidic acid

C16H19N2O3 (287.1396)


Indole-3-acetyl-isoleucine is also known as iaa-ile. Indole-3-acetyl-isoleucine is practically insoluble (in water) and a weakly acidic compound (based on its pKa). Indole-3-acetyl-isoleucine can be found in a number of food items such as oriental wheat, brazil nut, corn, and cauliflower, which makes indole-3-acetyl-isoleucine a potential biomarker for the consumption of these food products.

   

indole-3-acetyl-leucine

N-(1-Carboxy-3-methylbutyl)-2-(1H-indol-3-yl)ethanecarboximidic acid

C16H19N2O3- (287.1396)


Indole-3-acetyl-leucine is also known as iaa-leu. Indole-3-acetyl-leucine is practically insoluble (in water) and a weakly acidic compound (based on its pKa). Indole-3-acetyl-leucine can be found in a number of food items such as prairie turnip, pecan nut, common sage, and saffron, which makes indole-3-acetyl-leucine a potential biomarker for the consumption of these food products.

   
   

3,4-Flexinine

3,4-Flexinine

C16H17NO4 (287.1158)


   

6alpha-Hydroxycrinine

6alpha-Hydroxycrinine

C16H17NO4 (287.1158)


   

SCHEMBL19532552

SCHEMBL19532552

C17H21NO3 (287.1521)


   

Solanapyrone G

Solanapyrone G

C17H21NO3 (287.1521)


   

8-Oxo-alpha-erythroidine

8-Oxo-alpha-erythroidine

C16H17NO4 (287.1158)


   

Pancratinine C

Pancratinine C

C16H17NO4 (287.1158)


   
   

Noraugustamine

Noraugustamine

C16H17NO4 (287.1158)


   

Hyellazole

Hyellazole

C20H17NO (287.131)


   

Carajuron

6,7,4-Trihydroxy-5-methoxy-flavylium

C16H15O5 (287.0919)


   

1-hydroxy-3,6-dimethoxy-1,2-dimethyl-9H-carbazol-4-one

1-hydroxy-3,6-dimethoxy-1,2-dimethyl-9H-carbazol-4-one

C16H17NO4 (287.1158)


   

6beta-Hydroxycrinine

6beta-Hydroxycrinine

C16H17NO4 (287.1158)


   

(+)-11-Hydroxyvittatine

(+)-11-Hydroxyvittatine

C16H17NO4 (287.1158)


   
   
   

Benzoic acid, 4-hydroxy-2-((2-hydroxybenzoyl)amino)-, methyl ester

Benzoic acid, 4-hydroxy-2-((2-hydroxybenzoyl)amino)-, methyl ester

C15H13NO5 (287.0794)


   

2-acetamido-3,6-anhydro-2-deoxy-5-O-isovaleryl-D-glucofuranose|furanodictine A

2-acetamido-3,6-anhydro-2-deoxy-5-O-isovaleryl-D-glucofuranose|furanodictine A

C13H21NO6 (287.1369)


   
   

natsucitrine-I

natsucitrine-I

C15H13NO5 (287.0794)


   

Crinine, 6.alpha.-hydroxy-

Crinine, 6.alpha.-hydroxy-

C16H17NO4 (287.1158)


   

10-Decarbamoyloxy-9-dehydroporfiromycin

10-Decarbamoyloxy-9-dehydroporfiromycin

C15H17N3O3 (287.127)


   
   

Michigazone

Michigazone

C15H13NO5 (287.0794)


A member of the class phenoxazines that is 3H-phenoxazine substituted by methoxy, oxo, methoxy and hydroxymethyl groups at positions 2, 3, 4 and 8, respectively. It is a red pigment produced by the soil bacterium Streptomyces michiganensis.

   

Parvine

3,13,17-triazapentacyclo[11.8.0.0^{2,10}.0^{4,9}.0^{15,20}]henicosa-1(21),2(10),4(9),5,7,15(20),16,18-octaen-14-one

C18H13N3O (287.1059)


Parvine is a natural product found in Nauclea orientalis and Sarcocephalus latifolius with data available.

   
   

(+)-9-O-demethylhomolycorine

(+)-9-O-demethylhomolycorine

C16H17NO4 (287.1158)


   

9,14,14b,15-tetrahydro-8H-pyrido[4,3:4,5]azepino[1,2:1,2]pyrido[3,4-b]indole|Naufolin|Naufoline

9,14,14b,15-tetrahydro-8H-pyrido[4,3:4,5]azepino[1,2:1,2]pyrido[3,4-b]indole|Naufolin|Naufoline

C19H17N3 (287.1422)


   

8-oxo-beta-erythroidine

8-oxo-beta-erythroidine

C16H17NO4 (287.1158)


   
   
   

Isosalviamine A

Isosalviamine A

C19H13NO2 (287.0946)


   
   

Glycosparvarine

Glycosparvarine

C15H13NO5 (287.0794)


   
   

beta-D-glucopyranos-1-yl N-methylpyrrole-2-carboxylate

beta-D-glucopyranos-1-yl N-methylpyrrole-2-carboxylate

C12H17NO7 (287.1005)


   

1-hydroxy-8-epi-5,6,11-trideoxyTTX

1-hydroxy-8-epi-5,6,11-trideoxyTTX

C11H17N3O6 (287.1117)


   

3-methoxy-1,4,5-trihydroxy-10-methylacridone

3-methoxy-1,4,5-trihydroxy-10-methylacridone

C15H13NO5 (287.0794)


   

AV toxin E|AV-toxin E

AV toxin E|AV-toxin E

C15H13NO5 (287.0794)


   

(S)-2-(3,4-dihydroxybenzoylamino)-3-phenylpropanol|nigerrimin A

(S)-2-(3,4-dihydroxybenzoylamino)-3-phenylpropanol|nigerrimin A

C16H17NO4 (287.1158)


   

6,7-dihydro-5H-indolo[3,2:3,4]pyrido[2,1-b]quinazolin-9-one|Pseudorutaecarpin|rutaecarpine

6,7-dihydro-5H-indolo[3,2:3,4]pyrido[2,1-b]quinazolin-9-one|Pseudorutaecarpin|rutaecarpine

C18H13N3O (287.1059)


   

5,11-dideoxytetrodotoxin

5,11-dideoxytetrodotoxin

C11H17N3O6 (287.1117)


   

5-[(alpha-D-galactopyranosyloxy)methyl]-1H-pyrrole-2-carbaldehyde

5-[(alpha-D-galactopyranosyloxy)methyl]-1H-pyrrole-2-carbaldehyde

C12H17NO7 (287.1005)


   

6-[(alpha-D-galactopyranosyloxy)methyl]-3-pyridinol

6-[(alpha-D-galactopyranosyloxy)methyl]-3-pyridinol

C12H17NO7 (287.1005)


   
   

3-Isopentenyl-4-methoxy-7,8-methylendioxy-2-chinolon|6-methoxy-7-(3-methyl-but-2-enyl)-9H-[1,3]dioxolo[4,5-h]quinolin-8-one|6-methoxy-7-(3-methylbut-2-enyl)-1,3-dioxolo<4,5-h>quinolin-8-one

3-Isopentenyl-4-methoxy-7,8-methylendioxy-2-chinolon|6-methoxy-7-(3-methyl-but-2-enyl)-9H-[1,3]dioxolo[4,5-h]quinolin-8-one|6-methoxy-7-(3-methylbut-2-enyl)-1,3-dioxolo<4,5-h>quinolin-8-one

C16H17NO4 (287.1158)


   

4a-Dehydroxycrinamabine

4a-Dehydroxycrinamabine

C16H17NO4 (287.1158)


   

2-((2-Hydroxybenzoyl)amino)-4-methoxybenzoic acid

2-((2-Hydroxybenzoyl)amino)-4-methoxybenzoic acid

C15H13NO5 (287.0794)


   
   
   
   
   
   

SCHEMBL14952814

SCHEMBL14952814

C15H17N3O3 (287.127)


   
   
   
   
   
   
   
   

3-(4-chlorophenyl)-N-(3-methoxyphenyl)-2-propenamide

3-(4-chlorophenyl)-N-(3-methoxyphenyl)-2-propenamide

C16H14ClNO2 (287.0713)


   

2-carbazol-9-ylbenzoic acid

2-carbazol-9-ylbenzoic acid

C19H13NO2 (287.0946)


   

Tenofovir

D,L-Tenofovir;PMPA;TDF;Tenofovir disoproxil;Tenofovir disoproxil fumarate

C9H14N5O4P (287.0783)


C471 - Enzyme Inhibitor > C1589 - Reverse Transcriptase Inhibitor > C97452 - Nucleoside Reverse Transcriptase Inhibitor D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D018894 - Reverse Transcriptase Inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D004791 - Enzyme Inhibitors > D019384 - Nucleic Acid Synthesis Inhibitors C254 - Anti-Infective Agent > C281 - Antiviral Agent Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS CONFIDENCE standard compound; EAWAG_UCHEM_ID 3105 Tenofovir (GS 1278) is a nucleotide reverse transcriptase inhibitor to treat HIV and chronic Hepatitis B (HBV)[1].

   

Rutaecarpine

Rutaecarpine

C18H13N3O (287.1059)


Rutaecarpine, an alkaloid of Evodia rutaecarpa, is an inhibitor of COX-2 with an IC50 value of 0.28 μM. Rutaecarpine, an alkaloid of Evodia rutaecarpa, is an inhibitor of COX-2 with an IC50 value of 0.28 μM.

   

C16H17NO4_6,11-Methano-6H-benzo[b]-1,3-benzodioxolo[5,6-e]azepine-8,9-diol, 5,6a,7,8,9,11-hexahydro

NCGC00385948-01_C16H17NO4_6,11-Methano-6H-benzo[b]-1,3-benzodioxolo[5,6-e]azepine-8,9-diol, 5,6a,7,8,9,11-hexahydro-

C16H17NO4 (287.1158)


   

UNII-UGT5535REQ

UNII-UGT5535REQ

C17H18ClNO (287.1077)


   

Pyrophen

Pyrophen

C16H17NO4 (287.1158)


CONFIDENCE Penicillium sp.

   

C.I. Basic Red 9

C.I. Basic Red 9

C19H17N3 (287.1422)


D004396 - Coloring Agents > D012394 - Rosaniline Dyes D005404 - Fixatives CONFIDENCE standard compound; INTERNAL_ID 229; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 6850; ORIGINAL_PRECURSOR_SCAN_NO 6849 CONFIDENCE standard compound; INTERNAL_ID 229; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 6885; ORIGINAL_PRECURSOR_SCAN_NO 6883 CONFIDENCE standard compound; INTERNAL_ID 229; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 6893; ORIGINAL_PRECURSOR_SCAN_NO 6892 CONFIDENCE standard compound; INTERNAL_ID 229; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 6896; ORIGINAL_PRECURSOR_SCAN_NO 6895 CONFIDENCE standard compound; INTERNAL_ID 229; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 6827; ORIGINAL_PRECURSOR_SCAN_NO 6826 CONFIDENCE standard compound; INTERNAL_ID 229; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 6868; ORIGINAL_PRECURSOR_SCAN_NO 6867

   

1,N2-4-Oxo-(2E)-nonenal-guanine

1,N2-4-Oxo-(2E)-nonenal-guanine

C14H17N5O2 (287.1382)


   

noroxymorphone

Nor Oxymorphone

C16H17NO4 (287.1158)


D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist

   
   
   
   
   
   

Carboxyltolmetin

Carboxyltolmetin

C15H13NO5 (287.0794)


   

PARAROSANILINE

PARAROSANILINE

C19H17N3 (287.1422)


   

N-Ribosylhistidine

N-Ribosylhistidine

C11H17N3O6 (287.1117)


   

Barterin

4-hydroxy-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}cyclopent-2-ene-1-carbonitrile

C12H17NO7 (287.1005)


   

Citrusinine II

1,3,5-trihydroxy-4-methoxy-10-methyl-9,10-dihydroacridin-9-one

C15H13NO5 (287.0794)


   

Pipermethystine

6-oxo-1-(3-phenylpropanoyl)-1,2,3,6-tetrahydropyridin-3-yl acetate

C16H17NO4 (287.1158)


   

Clitocine

2-[(6-amino-5-nitropyrimidin-4-yl)amino]-5-(hydroxymethyl)oxolane-3,4-diol

C9H13N5O6 (287.0866)


Clitocine, an adenosine nucleoside analog isolated from mushroom, is a potent and efficacious readthrough agent. Clitocine acts as a suppressor of nonsense mutations and can induce the production of p53 protein in cells harboring p53 nonsense-mutated alleles. Clitocine can induce apoptosis in multidrug-resistant human cancer cells by targeting Mcl-1. Anticancer activity[1][2]. Clitocine, an adenosine nucleoside analog isolated from mushroom, is a potent and efficacious readthrough agent. Clitocine acts as a suppressor of nonsense mutations and can induce the production of p53 protein in cells harboring p53 nonsense-mutated alleles. Clitocine can induce apoptosis in multidrug-resistant human cancer cells by targeting Mcl-1. Anticancer activity[1][2].

   

Grandisine III

1,3,6-trihydroxy-5-methoxy-10-methyl-9,10-dihydroacridin-9-one

C15H13NO5 (287.0794)


   

SB-366791

N-(3-Methoxyphenyl)-4-chlorocinnamanilide

C16H14ClNO2 (287.0713)


   

CAR 6:2;O2

3-{[(2E)-5-carboxypent-2-enoyl]oxy}-4-(trimethylammonio)butanoate;trans-2-hexenedioylcarnitine

C13H21NO6 (287.1369)


   

Carajuron

6,7,4-Trihydroxy-5-methoxy-flavylium

C16H15O5+ (287.0919)


   

N4-Acetyl-2-Fluoro-2-deoxycytidine

N4-Acetyl-2-Fluoro-2-deoxycytidine

C11H14FN3O5 (287.0917)


   

4-hydroxy-3-[(2-nitro-phenyl)azo]-Benzeneethanol

4-hydroxy-3-[(2-nitro-phenyl)azo]-Benzeneethanol

C14H13N3O4 (287.0906)


   

Benzamide, N-[(4-hydroxyphenyl)methyl]-3,4-dimethoxy

Benzamide, N-[(4-hydroxyphenyl)methyl]-3,4-dimethoxy

C16H17NO4 (287.1158)


   

4-tert-butyl-2-[3-(trifluoromethyl)phenyl]morpholine

4-tert-butyl-2-[3-(trifluoromethyl)phenyl]morpholine

C15H20F3NO (287.1497)


   

N-(4-AMINO-6,7-DIMETHOXYQUINAZOL-2-YL)-N-METHYL-2-CYANOETHYLAMINE

N-(4-AMINO-6,7-DIMETHOXYQUINAZOL-2-YL)-N-METHYL-2-CYANOETHYLAMINE

C14H17N5O2 (287.1382)


   

AMINO-(4-BENZYLOXY-3-METHOXY-PHENYL)-ACETIC ACID

AMINO-(4-BENZYLOXY-3-METHOXY-PHENYL)-ACETIC ACID

C16H17NO4 (287.1158)


   

(9-Phenyl-9H-carbazol-3-yl)boronic acid

(9-Phenyl-9H-carbazol-3-yl)boronic acid

C18H14BNO2 (287.1118)


   

Formamide,N-(triphenylmethyl)-

Formamide,N-(triphenylmethyl)-

C20H17NO (287.131)


   

Methyl 4-(1-aminocyclopropyl)benzoate methanesulfonate (1:1)

Methyl 4-(1-aminocyclopropyl)benzoate methanesulfonate (1:1)

C12H17NO5S (287.0827)


   

Methyl 4-acetoxy-6-(dimethylamino)-2-naphthoate

Methyl 4-acetoxy-6-(dimethylamino)-2-naphthoate

C16H17NO4 (287.1158)


   

2,2,2-trifluoro-N-(6-oxo-6-phenylhexyl)acetamide

2,2,2-trifluoro-N-(6-oxo-6-phenylhexyl)acetamide

C14H16F3NO2 (287.1133)


   

2-Amino-N-(pyridin-3-ylmethyl)-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxamide

2-Amino-N-(pyridin-3-ylmethyl)-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxamide

C15H17N3OS (287.1092)


   

1,2,3-Triphenylguanidine

1,2,3-Triphenylguanidine

C19H17N3 (287.1422)


   

3-Pyrrolidinecarboxylic acid, 5-oxo-1-[[4-(trifluoromethyl)phenyl]methyl]-

3-Pyrrolidinecarboxylic acid, 5-oxo-1-[[4-(trifluoromethyl)phenyl]methyl]-

C13H12F3NO3 (287.0769)


   

(4-cyano-3,5-difluorophenyl) 4-ethylbenzoate

(4-cyano-3,5-difluorophenyl) 4-ethylbenzoate

C16H11F2NO2 (287.0758)


   

diethyl 6-methylquinoline-2,3-dicarboxylate

diethyl 6-methylquinoline-2,3-dicarboxylate

C16H17NO4 (287.1158)


   

Methyl 4-hydroxy-6-(4-morpholinyl)-2-naphthoate

Methyl 4-hydroxy-6-(4-morpholinyl)-2-naphthoate

C16H17NO4 (287.1158)


   

2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-_4-(trifluoromethyl)_benzenamine

2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-_4-(trifluoromethyl)_benzenamine

C13H17BF3NO2 (287.1304)


   

3-AZIDO-3-DEOXY-1,2:5,6-DI-O-ISOPROPYLIDENE-α-D-GLUCOFURANOSE

3-AZIDO-3-DEOXY-1,2:5,6-DI-O-ISOPROPYLIDENE-α-D-GLUCOFURANOSE

C11H17N3O6 (287.1117)


   

4-(9H-Carbozol-9-yl)phenylboronic acid

4-(9H-Carbozol-9-yl)phenylboronic acid

C18H14BNO2 (287.1118)


   

N-Boc-O-tosyl hydroxylamine

N-Boc-O-tosyl hydroxylamine

C12H17NO5S (287.0827)


   

4-(5-Chloro-1-isopropyl-1H-pyrrolo[2,3-c]pyridin-3-yl)pyrimidin-2-amine

4-(5-Chloro-1-isopropyl-1H-pyrrolo[2,3-c]pyridin-3-yl)pyrimidin-2-amine

C14H14ClN5 (287.0938)


   

5-Morpholin-4-ylmethyl-2-phenyl-furan-3-carboxylicacid

5-Morpholin-4-ylmethyl-2-phenyl-furan-3-carboxylicacid

C16H17NO4 (287.1158)


   

(S)-2-AMINOHEXANE

(S)-2-AMINOHEXANE

C13H15F2NO4 (287.0969)


   

3-(2-N-BOC-PYRROLE)BENZOICACID

3-(2-N-BOC-PYRROLE)BENZOICACID

C16H17NO4 (287.1158)


   

4-HYDROXY-7-CHLORO-3-IODOQUINOLINE

4-HYDROXY-7-CHLORO-3-IODOQUINOLINE

C14H16F3NO2 (287.1133)


   

1-[(4-fluorophenyl)methylamino]cyclohexane-1-carboxylic acid,hydrochloride

1-[(4-fluorophenyl)methylamino]cyclohexane-1-carboxylic acid,hydrochloride

C14H19ClFNO2 (287.1088)


   

1-(4-trifluoromethyl-benzyl)-piperidine-4-carboxylic acid hydrochloride

1-(4-trifluoromethyl-benzyl)-piperidine-4-carboxylic acid hydrochloride

C14H16F3NO2 (287.1133)


   

2-(Methylsulfonyl)-2,6-dihydropyrrolo[3,4-c]pyrazole-5(4H)-carboxylic acid tert-butyl ester

2-(Methylsulfonyl)-2,6-dihydropyrrolo[3,4-c]pyrazole-5(4H)-carboxylic acid tert-butyl ester

C11H17N3O4S (287.094)


   

1-butyl-1-methylpyrrolidinium hexafluorophosphate

1-butyl-1-methylpyrrolidinium hexafluorophosphate

C9H20F6NP (287.1237)


   

N-BENZYL-3-CARBOMETHOXY-4-PIPERIDONE, SODIUM SALT MONOHYDRATE, TECH.

N-BENZYL-3-CARBOMETHOXY-4-PIPERIDONE, SODIUM SALT MONOHYDRATE, TECH.

C14H18NNaO4 (287.1133)


   

Thionin acetate

Thionin acetate

C14H13N3O2S (287.0728)


D000890 - Anti-Infective Agents > D023181 - Antimicrobial Cationic Peptides

   

H-Gly-Gly-His-OH

H-Gly-Gly-His-OH

C10H17N5O5 (287.123)


   
   

3-BENZOYLAMINO-3-(4-FLUORO-PHENYL)-PROPIONIC ACID

3-BENZOYLAMINO-3-(4-FLUORO-PHENYL)-PROPIONIC ACID

C16H14FNO3 (287.0958)


   

2-(2-N-BOC-PYRROLE)BENZOICACID

2-(2-N-BOC-PYRROLE)BENZOICACID

C16H17NO4 (287.1158)


   

2-(7-FLUORO-2-(4-FLUOROPHENYL)-1H-INDOL-3-YL)ACETIC ACID

2-(7-FLUORO-2-(4-FLUOROPHENYL)-1H-INDOL-3-YL)ACETIC ACID

C16H11F2NO2 (287.0758)


   

(2S,4R)-1-(TERT-BUTOXYCARBONYL)-4-(2-METHOXY-2-OXOETHYL)PYRROLIDINE-2-CARBOXYLIC ACID

(2S,4R)-1-(TERT-BUTOXYCARBONYL)-4-(2-METHOXY-2-OXOETHYL)PYRROLIDINE-2-CARBOXYLIC ACID

C13H21NO6 (287.1369)


   

4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-(trifluoromethyl)aniline

4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-(trifluoromethyl)aniline

C13H17BF3NO2 (287.1304)


   

3-methoxy-4-(p-nitrobenzyloxy)benzaldehyde

3-methoxy-4-(p-nitrobenzyloxy)benzaldehyde

C15H13NO5 (287.0794)


   
   

2-(Diphenylmethyl)piperidine hydrochloride (1:1)

2-(Diphenylmethyl)piperidine hydrochloride (1:1)

C18H22ClN (287.1441)


   

Carbamimidothioic acid,N-cyano-N-[2-[[(4-methyl-1H-imidazol-5-yl)methyl]thio]ethyl]-, methyl ester

Carbamimidothioic acid,N-cyano-N-[2-[[(4-methyl-1H-imidazol-5-yl)methyl]thio]ethyl]-, methyl ester

C10H17N5OS2 (287.0874)


   

[2-(4-Methoxy-phenyl)-ethyl]-(4-methylsulfanyl-benzyl)-amine

[2-(4-Methoxy-phenyl)-ethyl]-(4-methylsulfanyl-benzyl)-amine

C17H21NOS (287.1344)


   

H-Tyr(But)-OmeHCl

H-Tyr(But)-OmeHCl

C14H22ClNO3 (287.1288)


   

Isoquinoline, 1,2,3,4-tetrahydro-2- (p-tolylsulfonyl)-

Isoquinoline, 1,2,3,4-tetrahydro-2- (p-tolylsulfonyl)-

C16H17NO2S (287.098)


   

2-chloro-7-methyl-3-(5-propyl-1,2,4-oxadiazol-3-yl)quinoline

2-chloro-7-methyl-3-(5-propyl-1,2,4-oxadiazol-3-yl)quinoline

C15H14ClN3O (287.0825)


   

2-chloro-8-methyl-3-(5-propyl-1,2,4-oxadiazol-3-yl)quinoline

2-chloro-8-methyl-3-(5-propyl-1,2,4-oxadiazol-3-yl)quinoline

C15H14ClN3O (287.0825)


   

2-chloro-6-methyl-3-(5-propyl-1,2,4-oxadiazol-3-yl)quinoline

2-chloro-6-methyl-3-(5-propyl-1,2,4-oxadiazol-3-yl)quinoline

C15H14ClN3O (287.0825)


   

(9-Phenyl-9H-carbazol-2-yl)boronic acid

(9-Phenyl-9H-carbazol-2-yl)boronic acid

C18H14BNO2 (287.1118)


   

2-(BIPHENYL-3-YL)-N-PHENYLACETAMIDE

2-(BIPHENYL-3-YL)-N-PHENYLACETAMIDE

C20H17NO (287.131)


   

2-Phenylthiazole-5-boronic acid pinacol ester

2-Phenylthiazole-5-boronic acid pinacol ester

C15H18BNO2S (287.1151)


   

2-CHLORO-4,5,7,8-TETRAHYDRO-6H-THIENO[2,3-D]AZEPINE-6-CARBOXYLIC ACID, T-BUTYLESTER

2-CHLORO-4,5,7,8-TETRAHYDRO-6H-THIENO[2,3-D]AZEPINE-6-CARBOXYLIC ACID, T-BUTYLESTER

C13H18ClNO2S (287.0747)


   

N2-(2-Quinolinylcarbonyl)-L-asparagine

N2-(2-Quinolinylcarbonyl)-L-asparagine

C14H13N3O4 (287.0906)


   

D-threo-beta-Methylsulfonylphenylserine ethyl ester

D-threo-beta-Methylsulfonylphenylserine ethyl ester

C12H17NO5S (287.0827)


   

3-Mercapto-6-methylpyridazine

3-Mercapto-6-methylpyridazine

C15H17N3O3 (287.127)


   

2-chloro-3-(5-isopropyl-1,2,4-oxadiazol-3-yl)-6-methylquinoline

2-chloro-3-(5-isopropyl-1,2,4-oxadiazol-3-yl)-6-methylquinoline

C15H14ClN3O (287.0825)


   

BTS 54-505 hydrochloride

BTS 54-505 hydrochloride

C15H23Cl2N (287.1207)


   

(3-((2-Isopropyl-1H-imidazol-1-yl)methyl)phenyl)amine dihydrochloride

(3-((2-Isopropyl-1H-imidazol-1-yl)methyl)phenyl)amine dihydrochloride

C13H19Cl2N3 (287.0956)


   

7,7-dimethyl-3-(thiophen-2-ylmethyl)-6,8-dihydro-1H-quinoline-2,5-dione

7,7-dimethyl-3-(thiophen-2-ylmethyl)-6,8-dihydro-1H-quinoline-2,5-dione

C16H17NO2S (287.098)


   

5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-(2,2,2-trifluoroethyl)pyridine

5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-(2,2,2-trifluoroethyl)pyridine

C13H17BF3NO2 (287.1304)


   

4-aminophenyl-1-thio-beta-d-galactopyranoside

4-aminophenyl-1-thio-beta-d-galactopyranoside

C12H17NO5S (287.0827)


   

ETHYL 7-METHYL-2-(2-THIENYL)PYRAZOLO[1,5-A]PYRIMIDINE-6-CARBOXYLATE

ETHYL 7-METHYL-2-(2-THIENYL)PYRAZOLO[1,5-A]PYRIMIDINE-6-CARBOXYLATE

C14H13N3O2S (287.0728)


   

8-METHYL-QUINOLINE-2,3-DICARBOXYLIC ACID DIETHYL ESTER

8-METHYL-QUINOLINE-2,3-DICARBOXYLIC ACID DIETHYL ESTER

C16H17NO4 (287.1158)


   

2-(2-quinolin-6-yl-1H-indol-3-yl)ethanamine

2-(2-quinolin-6-yl-1H-indol-3-yl)ethanamine

C19H17N3 (287.1422)


   

5-(4-(ACETYLAMINO)PHENYL)-1H-IMIDAZOLE-2-ACETIC ACID ETHYL ESTER

5-(4-(ACETYLAMINO)PHENYL)-1H-IMIDAZOLE-2-ACETIC ACID ETHYL ESTER

C15H17N3O3 (287.127)


   

H-Cys(Dpm)-OH

H-Cys(Dpm)-OH

C16H17NO2S (287.098)


   

3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5-(trifluoromethyl)aniline

3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5-(trifluoromethyl)aniline

C13H17BF3NO2 (287.1304)


   

(3R,4R)-1-[(tert-butoxy)carbonyl]-4-(ethoxycarbonyl)pyrrolidine-

(3R,4R)-1-[(tert-butoxy)carbonyl]-4-(ethoxycarbonyl)pyrrolidine-

C13H21NO6 (287.1369)


   

1-[4-(5-Nitro-1H-indol-3-yl)-1-piperidinyl]ethanone

1-[4-(5-Nitro-1H-indol-3-yl)-1-piperidinyl]ethanone

C15H17N3O3 (287.127)


   

Methyl 6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylate

Methyl 6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylate

C13H18ClNO4 (287.0924)


   

1-[BIS-(4-FLUOROPHENYL)-METHYL]-PIPERIDINE

1-[BIS-(4-FLUOROPHENYL)-METHYL]-PIPERIDINE

C18H19F2N (287.1485)


   

5-METHOXY-N-(2-(THIOPHEN-2-YL)ETHYL)-1,2,3,4-TETRAHYDRONAPHTHALEN-2-AMINE

5-METHOXY-N-(2-(THIOPHEN-2-YL)ETHYL)-1,2,3,4-TETRAHYDRONAPHTHALEN-2-AMINE

C17H21NOS (287.1344)


   

3-(METHOXYCARBONYL)-1-(2-ETHOXYETHYL)-4-NITRO-1H-PYRAZOLE-5-CARBOXYLIC ACID

3-(METHOXYCARBONYL)-1-(2-ETHOXYETHYL)-4-NITRO-1H-PYRAZOLE-5-CARBOXYLIC ACID

C10H13N3O7 (287.0753)


   

2-Amino-6-benzyl-4,5,6,7-tetrahydro-thieno[2,3-c]pyridine-3-carboxylic acid amide

2-Amino-6-benzyl-4,5,6,7-tetrahydro-thieno[2,3-c]pyridine-3-carboxylic acid amide

C15H17N3OS (287.1092)


   

3-(Dipropylamino)-4-methoxybenzenesulfonic acid

3-(Dipropylamino)-4-methoxybenzenesulfonic acid

C13H21NO4S (287.1191)


   

ethyl 2-(2-ethoxy-2-oxoethyl)quinoline-3-carboxylate

ethyl 2-(2-ethoxy-2-oxoethyl)quinoline-3-carboxylate

C16H17NO4 (287.1158)


   

2-methyl-N-naphthalen-1-yl-N-phenylprop-2-enamide

2-methyl-N-naphthalen-1-yl-N-phenylprop-2-enamide

C20H17NO (287.131)


   

3-((tert-Butoxycarbonyl)amino)-2-naphthoic acid

3-((tert-Butoxycarbonyl)amino)-2-naphthoic acid

C16H17NO4 (287.1158)


   

3-amino-N,N-diethyl-4-(2-hydroxyethylamino)benzenesulfonamide

3-amino-N,N-diethyl-4-(2-hydroxyethylamino)benzenesulfonamide

C12H21N3O3S (287.1304)


   

4-(BENZYLOXY)-5-METHOXY-2-NITROBENZALDEHYDE

4-(BENZYLOXY)-5-METHOXY-2-NITROBENZALDEHYDE

C15H13NO5 (287.0794)


   

Ethyl N-[(5-amino-1-phenyl-1H-pyrazol-4-yl)-carbonyl]ethanehydrazonoate

Ethyl N-[(5-amino-1-phenyl-1H-pyrazol-4-yl)-carbonyl]ethanehydrazonoate

C14H17N5O2 (287.1382)


   

[3-(9H-Carbazol-9-yl)phenyl]boronic acid

[3-(9H-Carbazol-9-yl)phenyl]boronic acid

C18H14BNO2 (287.1118)


   

3,6-Acridinediamine,N6,N6,2-trimethyl-, hydrochloride (1:1)

3,6-Acridinediamine,N6,N6,2-trimethyl-, hydrochloride (1:1)

C16H18ClN3 (287.1189)


   

BIO-013077-01

BIO-013077-01

C17H13N5 (287.1171)


   

2-Chloro-N-(3,3-diphenylpropyl)acetamide

2-Chloro-N-(3,3-diphenylpropyl)acetamide

C17H18ClNO (287.1077)


   

1H-Benz[de]isoquinoline-1,3(2H)-dione,2-(phenylmethyl)-

1H-Benz[de]isoquinoline-1,3(2H)-dione,2-(phenylmethyl)-

C19H13NO2 (287.0946)


   

(3-(N-(tert-butyl)sulfamoyl)-4-Methoxyphenyl)boronic acid

(3-(N-(tert-butyl)sulfamoyl)-4-Methoxyphenyl)boronic acid

C11H18BNO5S (287.0999)


   

(S)-(+)-2-AMINO-2-PHENYLBUTYRICACID

(S)-(+)-2-AMINO-2-PHENYLBUTYRICACID

C16H17NO2S (287.098)


   

4-Aminophenyl b-D-thiomannopyranoside

4-Aminophenyl b-D-thiomannopyranoside

C12H17NO5S (287.0827)


   

1-(4-(4-Amino-2-(trifluoromethyl)phenyl)piperazin-1-yl)ethanone

1-(4-(4-Amino-2-(trifluoromethyl)phenyl)piperazin-1-yl)ethanone

C13H16F3N3O (287.1245)


   

3-(4-(methylsulfonyl)phenyl)serine ethyl ester

3-(4-(methylsulfonyl)phenyl)serine ethyl ester

C12H17NO5S (287.0827)


   

TRANS-1-(tert-butoxycarbonyl)-4-(ethoxycarbonyl)pyrrolidine-3-carboxylic acid

TRANS-1-(tert-butoxycarbonyl)-4-(ethoxycarbonyl)pyrrolidine-3-carboxylic acid

C13H21NO6 (287.1369)


   

1-(4-(benzyloxy)-2-hydroxy-3-nitrophenyl)ethanone

1-(4-(benzyloxy)-2-hydroxy-3-nitrophenyl)ethanone

C15H13NO5 (287.0794)


   

2-(4-(ETHYLAMINO)PHENYL)-1,1,1,3,3,3-HEXAFLUOROPROPAN-2-OL

2-(4-(ETHYLAMINO)PHENYL)-1,1,1,3,3,3-HEXAFLUOROPROPAN-2-OL

C11H11F6NO (287.0745)


   

1-Benzyl-4-thiophen-2-yl-pyrrolidine-3-carboxylic acid

1-Benzyl-4-thiophen-2-yl-pyrrolidine-3-carboxylic acid

C16H17NO2S (287.098)


   

2-chloro-1-(3-phenyl-2,3-dihydro-1,4-benzoxazin-4-yl)ethanone

2-chloro-1-(3-phenyl-2,3-dihydro-1,4-benzoxazin-4-yl)ethanone

C16H14ClNO2 (287.0713)


   

1-[(3-fluorophenyl)methylamino]cyclohexane-1-carboxylic acid

1-[(3-fluorophenyl)methylamino]cyclohexane-1-carboxylic acid

C14H19ClFNO2 (287.1088)


   

Methyl 2-amino-4-methoxy-5-(phenylmethoxy)benzoate

Methyl 2-amino-4-methoxy-5-(phenylmethoxy)benzoate

C16H17NO4 (287.1158)


   

L-Ser(Bzl)-OtBu.HCl

L-Ser(Bzl)-OtBu.HCl

C14H22ClNO3 (287.1288)


   

2-((2-Carboxyphenyl)amino)-3-methoxybenzoic acid

2-((2-Carboxyphenyl)amino)-3-methoxybenzoic acid

C15H13NO5 (287.0794)


   

4-(2-Morpholinoethoxy)phenylboronic acid, HCl

4-(2-Morpholinoethoxy)phenylboronic acid, HCl

C12H19BClNO4 (287.1096)


   

Methyl 2-amino-4-benzyloxy-5-methoxybenzoate

Methyl 2-amino-4-benzyloxy-5-methoxybenzoate

C16H17NO4 (287.1158)


   
   

besipirdine

Besipirdine hydrochloride

C16H18ClN3 (287.1189)


C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist

   

(2Z)-3-(Acetylamino)-4-(2,4,5-trifluorophenyl)-2-butenoic acid methyl ester

(2Z)-3-(Acetylamino)-4-(2,4,5-trifluorophenyl)-2-butenoic acid methyl ester

C13H12F3NO3 (287.0769)


   

2-[4-(3-FORMYL-2,5-DIMETHYL-1H-1-PYRROLYL)PHENOXY]PROPANOIC ACID

2-[4-(3-FORMYL-2,5-DIMETHYL-1H-1-PYRROLYL)PHENOXY]PROPANOIC ACID

C16H17NO4 (287.1158)


   

Furo[2,3-d]pyrimidin-4-amine,5,6-diphenyl-

Furo[2,3-d]pyrimidin-4-amine,5,6-diphenyl-

C18H13N3O (287.1059)


   

N-(2-Chloropyrimidin-4-yl)-N-methyl-2,3-dimethyl-2H-indazol-6-amine

N-(2-Chloropyrimidin-4-yl)-N-methyl-2,3-dimethyl-2H-indazol-6-amine

C14H14ClN5 (287.0938)


   

N-ACETYL-N-(2-ISOPROPYL-4-OXO-3(4H)-QUI&

N-ACETYL-N-(2-ISOPROPYL-4-OXO-3(4H)-QUI&

C15H17N3O3 (287.127)


   

Benzamide,N-(diphenylmethyl)-

Benzamide,N-(diphenylmethyl)-

C20H17NO (287.131)


   

5-Benzyloxy-4-methoxy-2-nitrobenzaldehyde

5-Benzyloxy-4-methoxy-2-nitrobenzaldehyde

C15H13NO5 (287.0794)


   

P-AMINOPHENYL-1-THIO-β-D-GLUCOPYRANOS IDE

P-AMINOPHENYL-1-THIO-β-D-GLUCOPYRANOS IDE

C12H17NO5S (287.0827)


   

2-chloro-6-(3-hydroxypropylamino)phenalen-1-one

2-chloro-6-(3-hydroxypropylamino)phenalen-1-one

C16H14ClNO2 (287.0713)


   

9-ACETYL-7-METHYL-2-MORPHOLINO-4H-PYRIDO[1,2-A]PYRIMIDIN-4-ONE

9-ACETYL-7-METHYL-2-MORPHOLINO-4H-PYRIDO[1,2-A]PYRIMIDIN-4-ONE

C15H17N3O3 (287.127)


   

1-[2-Hydroxy-3-nitro-5-(phenylmethoxy)phenyl]ethanone

1-[2-Hydroxy-3-nitro-5-(phenylmethoxy)phenyl]ethanone

C15H13NO5 (287.0794)


   

4-(2-morpholin-4-ylethoxy)benzoic acid,hydrochloride

4-(2-morpholin-4-ylethoxy)benzoic acid,hydrochloride

C13H18ClNO4 (287.0924)


   

5-(4-chlorophenyl)-N-cyclopentyl-2-methylpyrimidin-4-amine

5-(4-chlorophenyl)-N-cyclopentyl-2-methylpyrimidin-4-amine

C16H18ClN3 (287.1189)


   

6-(2-CHLOROPHENYL)-4,4-DIMETHYL-1H-BENZO[D][1,3]OXAZIN-2(4H)-ONE

6-(2-CHLOROPHENYL)-4,4-DIMETHYL-1H-BENZO[D][1,3]OXAZIN-2(4H)-ONE

C16H14ClNO2 (287.0713)


   

6-(3-CHLOROPHENYL)-4,4-DIMETHYL-1H-BENZO[D][1,3]OXAZIN-2(4H)-ONE

6-(3-CHLOROPHENYL)-4,4-DIMETHYL-1H-BENZO[D][1,3]OXAZIN-2(4H)-ONE

C16H14ClNO2 (287.0713)


   

N-(3-METHYLPHENYL)-N-[4-(PHENYLAZO)PHENYL]AMINE

N-(3-METHYLPHENYL)-N-[4-(PHENYLAZO)PHENYL]AMINE

C19H17N3 (287.1422)


   

4-Ethyl-5-(5-phenyl-tetrazol-2-ylmethyl)-4H-[1,2,4]triazole-3-thiol

4-Ethyl-5-(5-phenyl-tetrazol-2-ylmethyl)-4H-[1,2,4]triazole-3-thiol

C12H13N7S (287.0953)


   

trolamine salicylate

trolamine salicylate

C13H21NO6 (287.1369)


D000893 - Anti-Inflammatory Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D012459 - Salicylates C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic

   

cefbuperazone side chain

cefbuperazone side chain

C11H17N3O6 (287.1117)


   

Phenol,3-nitro-4-(phenylMethoxy)-,acetate(ester)

Phenol,3-nitro-4-(phenylMethoxy)-,acetate(ester)

C15H13NO5 (287.0794)


   

Methyl 2-(benzyloxy)-3-nitrobenzoate

Methyl 2-(benzyloxy)-3-nitrobenzoate

C15H13NO5 (287.0794)


   

4-C-azido-2-deoxy-2-fluoro-beta-D-arabinouridine

4-C-azido-2-deoxy-2-fluoro-beta-D-arabinouridine

C9H10FN5O5 (287.0666)


   

B-[2-(9H-Carbazol-9-yl)phenyl]boronic acid

B-[2-(9H-Carbazol-9-yl)phenyl]boronic acid

C18H14BNO2 (287.1118)


   

(9-phenyl-carbazol-1-yl)boronic acid

(9-phenyl-carbazol-1-yl)boronic acid

C18H14BNO2 (287.1118)


   

N-(3,5-Dimethoxyphenyl)-4-methoxybenzamide

N-(3,5-Dimethoxyphenyl)-4-methoxybenzamide

C16H17NO4 (287.1158)


   

2-O-Methyl-2-O-ethyluridine

2-O-Methyl-2-O-ethyluridine

C12H19N2O6 (287.1243)


   

4-C-azido-3-deoxy-3-fluoro-Uridine

4-C-azido-3-deoxy-3-fluoro-Uridine

C9H10FN5O5 (287.0666)


   

5-Carboxycytidine

5-Carboxycytidine

C10H13N3O7 (287.0753)


   

3-(N-CBZ-AMINO)-5-HYDROXYBENZOIC ACID

3-(N-CBZ-AMINO)-5-HYDROXYBENZOIC ACID

C15H13NO5 (287.0794)


   

1-[4-(4-AMINO-2-TRIFLUOROMETHYLPHENYL)PIPERAZIN-1-YL]ETHANONE

1-[4-(4-AMINO-2-TRIFLUOROMETHYLPHENYL)PIPERAZIN-1-YL]ETHANONE

C13H16F3N3O (287.1245)


   

Gonyautoxin IV

Gonyautoxin IV

C8H21N3O4S2 (287.0973)


From Gonyaulax and Protogonyaulax subspecies Gonyautoxin IV is found in mollusks.

   

4-methoxy-3-(n,n-diethylsulfamoyl)phenylboronic acid

4-methoxy-3-(n,n-diethylsulfamoyl)phenylboronic acid

C11H18BNO5S (287.0999)


   

4-((2-NITROBENZYL)OXY)-3-METHOXYBENZALDEHYDE

4-((2-NITROBENZYL)OXY)-3-METHOXYBENZALDEHYDE

C15H13NO5 (287.0794)


   

1-(1,3-dimethylpyrazol-4-yl)sulfonylpiperidine-4-carboxylic acid

1-(1,3-dimethylpyrazol-4-yl)sulfonylpiperidine-4-carboxylic acid

C11H17N3O4S (287.094)


   

3-PHENYL-2-(4,4,4-TRIFLUORO-3-OXO-BUT-1-ENYLAMINO)-PROPIONIC ACID

3-PHENYL-2-(4,4,4-TRIFLUORO-3-OXO-BUT-1-ENYLAMINO)-PROPIONIC ACID

C13H12F3NO3 (287.0769)


   

(4S)-(-)-T-BUTYLDIMETHYLSILOXY-2-CYCLOPENTEN-1-ONE

(4S)-(-)-T-BUTYLDIMETHYLSILOXY-2-CYCLOPENTEN-1-ONE

C16H17NO4 (287.1158)


   

1-cyclopropyl-6-fluoro-7-piperazin-1-ylquinolin-4-one

1-cyclopropyl-6-fluoro-7-piperazin-1-ylquinolin-4-one

C16H18FN3O (287.1434)


   

6-(4-CHLOROPHENYL)-4,4-DIMETHYL-1H-BENZO[D][1,3]OXAZIN-2(4H)-ONE

6-(4-CHLOROPHENYL)-4,4-DIMETHYL-1H-BENZO[D][1,3]OXAZIN-2(4H)-ONE

C16H14ClNO2 (287.0713)


   

3-(6-(trifluoromethyl)pyrazolo[1,5-a]pyridin-2-yl)benzonitrile

3-(6-(trifluoromethyl)pyrazolo[1,5-a]pyridin-2-yl)benzonitrile

C15H8F3N3 (287.067)


   

methyl 4-[(4-nitrophenyl)methoxy]benzoate

methyl 4-[(4-nitrophenyl)methoxy]benzoate

C15H13NO5 (287.0794)


   

4-[(4-METHOXYBENZYLIDENE)AMINO]BIPHENYL

4-[(4-METHOXYBENZYLIDENE)AMINO]BIPHENYL

C20H17NO (287.131)


   

3-(3-(3,4-Dichlorophenyl)piperidin-3-yl)propan-1-ol

3-(3-(3,4-Dichlorophenyl)piperidin-3-yl)propan-1-ol

C14H19Cl2NO (287.0844)


   

Boc-L-glutamic acid γ-allyl ester

Boc-L-glutamic acid γ-allyl ester

C13H21NO6 (287.1369)


   

2,6-diphenyl-4-piperidone hcl

2,6-diphenyl-4-piperidone hcl

C17H18ClNO (287.1077)


   
   
   

Pentopyranic acid

Pentopyranic acid

C10H13N3O7 (287.0753)


   

7-Chloro-3-methyl-1-phenyl-1,2,4,5-tetrahydro-3-benzazepin-8-ol

7-Chloro-3-methyl-1-phenyl-1,2,4,5-tetrahydro-3-benzazepin-8-ol

C17H18ClNO (287.1077)


   

2,6-Dihydroxy-N-(2-(4-methoxyphenyl)ethyl)benzamide

2,6-Dihydroxy-N-(2-(4-methoxyphenyl)ethyl)benzamide

C16H17NO4 (287.1158)


   

(R)-2,3,4,5-Tetrahydro-8-chloro-3-methyl-5-phenyl-1H-3-benzazepin-7-ol

(R)-2,3,4,5-Tetrahydro-8-chloro-3-methyl-5-phenyl-1H-3-benzazepin-7-ol

C17H18ClNO (287.1077)


   

2H-Indol-2-one, 1,3-dihydro-5-(3-pyridinyl)-3-(1H-pyrrol-2-ylmethylene)-

2H-Indol-2-one, 1,3-dihydro-5-(3-pyridinyl)-3-(1H-pyrrol-2-ylmethylene)-

C18H13N3O (287.1059)


   

2,5-dimethyl-N-[(E)-(2-nitrophenyl)methylideneamino]furan-3-carboxamide

2,5-dimethyl-N-[(E)-(2-nitrophenyl)methylideneamino]furan-3-carboxamide

C14H13N3O4 (287.0906)


   

1H-Pyrrole-1-acetic acid, 3-(ethoxycarbonyl)-2-methyl-5-phenyl-

1H-Pyrrole-1-acetic acid, 3-(ethoxycarbonyl)-2-methyl-5-phenyl-

C16H17NO4 (287.1158)


   

2-(9h-Carbazol-9-yl)benzoic acid

2-(9h-Carbazol-9-yl)benzoic acid

C19H13NO2 (287.0946)


   

2-(4-Fluorophenyl)-2-oxoethyl 2-(methylamino)benzoate

2-(4-Fluorophenyl)-2-oxoethyl 2-(methylamino)benzoate

C16H14FNO3 (287.0958)


   

3-(4-chlorophenyl)-5-propyl-1H-pyrazolo[1,5-a]pyrimidin-7-one

3-(4-chlorophenyl)-5-propyl-1H-pyrazolo[1,5-a]pyrimidin-7-one

C15H14ClN3O (287.0825)


   

8-(Hydroxymethyl)-2,4-dimethoxyphenoxazin-3-one

8-(Hydroxymethyl)-2,4-dimethoxyphenoxazin-3-one

C15H13NO5 (287.0794)


   

N-(3,4-dimethoxyphenyl)-4-methoxybenzamide

N-(3,4-dimethoxyphenyl)-4-methoxybenzamide

C16H17NO4 (287.1158)


   

5-Methylaminomethyluridine

5-Methylaminomethyluridine

C11H17N3O6 (287.1117)


   

4-Diazoniophenylphosphorylcholine

4-Diazoniophenylphosphorylcholine

C11H18N3O4P+2 (287.1035)


   

N-(3-methoxyphenyl)-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxamide

N-(3-methoxyphenyl)-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxamide

C16H17NO2S (287.098)


   

2-(4-methoxyphenoxy)-N-(2-methoxyphenyl)acetamide

2-(4-methoxyphenoxy)-N-(2-methoxyphenyl)acetamide

C16H17NO4 (287.1158)


   

4-Methyl-2-(8-quinolinyl)-1-phthalazinone

4-Methyl-2-(8-quinolinyl)-1-phthalazinone

C18H13N3O (287.1059)


   

4-(5-(1,3-Benzodioxol-5-yl)-1-oxo-2,4-pentadienyl)morpholine

4-(5-(1,3-Benzodioxol-5-yl)-1-oxo-2,4-pentadienyl)morpholine

C16H17NO4 (287.1158)


   

(4S)-4-(2-Naphthylmethyl)-D-glutamic acid

(4S)-4-(2-Naphthylmethyl)-D-glutamic acid

C16H17NO4 (287.1158)


   

(3,4,5-Trihydroxy-6-hydroxymethyl-tetrahydro-pyran-2-YL)-phosphoramidic acid dimethyl ester

(3,4,5-Trihydroxy-6-hydroxymethyl-tetrahydro-pyran-2-YL)-phosphoramidic acid dimethyl ester

C8H18NO8P (287.077)


   

Incadronic

Incadronic acid

C8H19NO6P2 (287.0688)


C78281 - Agent Affecting Musculoskeletal System > C67439 - Bone Resorption Inhibitor D050071 - Bone Density Conservation Agents > D004164 - Diphosphonates

   

11-Hydroxyvittatine

11-Hydroxyvittatine

C16H17NO4 (287.1158)


   

5-Deoxy-dihydrokalafungin

5-Deoxy-dihydrokalafungin

C16H15O5- (287.0919)


   

Indole-3-acetyl-leu

Indole-3-acetyl-leu

C16H19N2O3- (287.1396)


   

(indol-3-yl)acetyl-L-isoleucine

(indol-3-yl)acetyl-L-isoleucine

C16H19N2O3- (287.1396)


   

(E)-3-(4-Chlorophenyl)-N-(4-methoxyphenyl)prop-2-enamide

(E)-3-(4-Chlorophenyl)-N-(4-methoxyphenyl)prop-2-enamide

C16H14ClNO2 (287.0713)


   

2-amino-6-chloro-9-[5-(hydroxymethyl)oxolan-2-yl]-3H-purin-6-ol

2-amino-6-chloro-9-[5-(hydroxymethyl)oxolan-2-yl]-3H-purin-6-ol

C10H14ClN5O3 (287.0785)


D009676 - Noxae > D000963 - Antimetabolites > D015224 - Dideoxynucleosides

   

Hex-3-enedioylcarnitine

Hex-3-enedioylcarnitine

C13H21NO6 (287.1369)


   

indole-3-acetyl-isoleucine

indole-3-acetyl-isoleucine

C16H19N2O3- (287.1396)


   

(2E)-3-Methylpent-2-enedioylcarnitine

(2E)-3-Methylpent-2-enedioylcarnitine

C13H21NO6 (287.1369)


   

1,4,8-Trimethyl-12-quinolino[2,3-b]quinolinamine

1,4,8-Trimethyl-12-quinolino[2,3-b]quinolinamine

C19H17N3 (287.1422)


   

N-Acetyl-ala-ala-ala-methylester

N-Acetyl-ala-ala-ala-methylester

C12H21N3O5 (287.1481)


   

Tetraphyllin B

Tetraphyllin B

C12H17NO7 (287.1005)


   

3,7-Diamino-5-phenylphenazin-5-ium

3,7-Diamino-5-phenylphenazin-5-ium

C18H15N4+ (287.1297)


   

N-(2,6-dimethoxy-4-pyrimidinyl)-3-phenylpropanamide

N-(2,6-dimethoxy-4-pyrimidinyl)-3-phenylpropanamide

C15H17N3O3 (287.127)


   

2-methoxy-N-(4-methylphenyl)-4-(methylthio)benzamide

2-methoxy-N-(4-methylphenyl)-4-(methylthio)benzamide

C16H17NO2S (287.098)


   

N-[5-[(2,2-dimethyl-1-oxopropyl)amino]-2-pyridinyl]-2-furancarboxamide

N-[5-[(2,2-dimethyl-1-oxopropyl)amino]-2-pyridinyl]-2-furancarboxamide

C15H17N3O3 (287.127)


   

2-(2-methylphenoxy)-N-[2-(methylthio)phenyl]acetamide

2-(2-methylphenoxy)-N-[2-(methylthio)phenyl]acetamide

C16H17NO2S (287.098)


   

N-(2,3-dihydro-1,4-benzodioxin-3-ylmethyl)-5-ethyl-2-furancarboxamide

N-(2,3-dihydro-1,4-benzodioxin-3-ylmethyl)-5-ethyl-2-furancarboxamide

C16H17NO4 (287.1158)


   

2-[6-(Methoxymethyl)-4-oxo-1,4-dihydropyrimidin-2-yl]-1-(4-methylphenyl)guanidine

2-[6-(Methoxymethyl)-4-oxo-1,4-dihydropyrimidin-2-yl]-1-(4-methylphenyl)guanidine

C14H17N5O2 (287.1382)


   

(17S,18S)-5,7-Dioxa-12-azapentacyclo[10.6.1.02,10.04,8.015,19]nonadeca-2,4(8),9,15-tetraene-17,18-diol

(17S,18S)-5,7-Dioxa-12-azapentacyclo[10.6.1.02,10.04,8.015,19]nonadeca-2,4(8),9,15-tetraene-17,18-diol

C16H17NO4 (287.1158)


   

(2-oxooxolan-3-yl) (E)-2-cyano-3-(4-methoxyphenyl)prop-2-enoate

(2-oxooxolan-3-yl) (E)-2-cyano-3-(4-methoxyphenyl)prop-2-enoate

C15H13NO5 (287.0794)


   

(2S,3R)-2-[[(2S)-1-[(2S)-2-aminopropanoyl]pyrrolidine-2-carbonyl]amino]-3-hydroxybutanoic acid

(2S,3R)-2-[[(2S)-1-[(2S)-2-aminopropanoyl]pyrrolidine-2-carbonyl]amino]-3-hydroxybutanoic acid

C12H21N3O5 (287.1481)


   
   

2-benzylidene-6-methyl-2,3,4,9-tetrahydro-1H-carbazol-1-one

2-benzylidene-6-methyl-2,3,4,9-tetrahydro-1H-carbazol-1-one

C20H17NO (287.131)


   

2-[(3-Butan-2-yl-4-oxo-2-quinazolinyl)thio]propanenitrile

2-[(3-Butan-2-yl-4-oxo-2-quinazolinyl)thio]propanenitrile

C15H17N3OS (287.1092)


   

5-(2,3-dihydro-1H-indol-1-ylmethylene)-1-methyl-2-thioxodihydro-4,6(1H,5H)-pyrimidinedione

5-(2,3-dihydro-1H-indol-1-ylmethylene)-1-methyl-2-thioxodihydro-4,6(1H,5H)-pyrimidinedione

C14H13N3O2S (287.0728)


   

3-[2-(4-Methylphenyl)-5-tetrazolyl]quinoline

3-[2-(4-Methylphenyl)-5-tetrazolyl]quinoline

C17H13N5 (287.1171)


   

2-(4-Chlorophenyl)-5-(1-piperidinyl)-4-oxazolecarbonitrile

2-(4-Chlorophenyl)-5-(1-piperidinyl)-4-oxazolecarbonitrile

C15H14ClN3O (287.0825)


   

1-(2-Ethyl-6-methylphenyl)-3-[(1-methyl-2-pyrrolyl)methyl]thiourea

1-(2-Ethyl-6-methylphenyl)-3-[(1-methyl-2-pyrrolyl)methyl]thiourea

C16H21N3S (287.1456)


   

4-[4-(3-Chlorophenyl)piperazin-1-yl]aniline

4-[4-(3-Chlorophenyl)piperazin-1-yl]aniline

C16H18ClN3 (287.1189)


   

6-[(4-Chloroanilino)methylidene]-3-prop-2-enoxy-1-cyclohexa-2,4-dienone

6-[(4-Chloroanilino)methylidene]-3-prop-2-enoxy-1-cyclohexa-2,4-dienone

C16H14ClNO2 (287.0713)


   

5,7-dimethyl-3-(4-methylphenyl)-3H-pyrido[4,3,2-de]quinazoline

5,7-dimethyl-3-(4-methylphenyl)-3H-pyrido[4,3,2-de]quinazoline

C19H17N3 (287.1422)


   

5-(1,3-dioxoisoindol-2-yl)-1H-indole-3-carbonitrile

5-(1,3-dioxoisoindol-2-yl)-1H-indole-3-carbonitrile

C17H9N3O2 (287.0695)


   

6-acetyl-6-amino-3-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-pyrimidin-2-one

6-acetyl-6-amino-3-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-pyrimidin-2-one

C11H17N3O6 (287.1117)


   

Asp-Gly-Pro

Asp-Gly-Pro

C11H17N3O6 (287.1117)


A tripeptide composed of L-aspartic acid, glycine, and L-proline units joined in sequence.

   
   
   
   
   

[4-(2-Pyridinylmethyl)-1-piperazinyl]-thiophen-2-ylmethanone

[4-(2-Pyridinylmethyl)-1-piperazinyl]-thiophen-2-ylmethanone

C15H17N3OS (287.1092)


   

8,8-dimethyl-2,9-dioxo-10H-pyrano[2,3-f][1]benzopyran-10-carboxaldehyde oxime

8,8-dimethyl-2,9-dioxo-10H-pyrano[2,3-f][1]benzopyran-10-carboxaldehyde oxime

C15H13NO5 (287.0794)


   

(2R)-2-[(2S,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyacetamide

(2R)-2-[(2S,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyacetamide

C10H13N3O7 (287.0753)


   

N-butyl-1,6-dihydro-5-(4-hydroxyphenyl)-6-oxo-2-pyrazinecarboxamide

N-butyl-1,6-dihydro-5-(4-hydroxyphenyl)-6-oxo-2-pyrazinecarboxamide

C15H17N3O3 (287.127)


   
   
   
   
   
   

(2E)-8-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]oct-2-enoate

(2E)-8-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]oct-2-enoate

C14H23O6- (287.1495)


   

(E,7R)-7-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxyoct-2-enoate

(E,7R)-7-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxyoct-2-enoate

C14H23O6- (287.1495)


   

2-(2,5-Dimethoxyphenyl)-4-methyl-1,6-dihydroimidazo[4,5-d]pyridazin-3-ium-7-one

2-(2,5-Dimethoxyphenyl)-4-methyl-1,6-dihydroimidazo[4,5-d]pyridazin-3-ium-7-one

C14H15N4O3+ (287.1144)


   

2-[(4,4-Dimethyl-2,6-dioxocyclohexyl)methylideneamino]benzoic acid

2-[(4,4-Dimethyl-2,6-dioxocyclohexyl)methylideneamino]benzoic acid

C16H17NO4 (287.1158)


   

5-amino-1-(3-fluoro-4-morpholinophenyl)-1H-imidazole-4-carbonitrile

5-amino-1-(3-fluoro-4-morpholinophenyl)-1H-imidazole-4-carbonitrile

C14H14FN5O (287.1182)


   

N-Acetyl-glycyl-valyl-glycine methylester

N-Acetyl-glycyl-valyl-glycine methylester

C12H21N3O5 (287.1481)


   

N-Acetyl-alanyl-alanyl-alanine methyl ester

N-Acetyl-alanyl-alanyl-alanine methyl ester

C12H21N3O5 (287.1481)


   

4-Ethoxycarbonylmethyl-3-methyl-1-para-tolyl-3-pyrroline-2,5-dione

4-Ethoxycarbonylmethyl-3-methyl-1-para-tolyl-3-pyrroline-2,5-dione

C16H17NO4 (287.1158)


   

1-Methyl-3-methoxycarbonyl-5-trimethylsilyl-2-phenylpyrrole

1-Methyl-3-methoxycarbonyl-5-trimethylsilyl-2-phenylpyrrole

C16H21NO2Si (287.1341)


   

6,11-Phenylimino-5,6-dihydropyrrolo(1,2-C)(1,3)benzodiazepin-5-one

6,11-Phenylimino-5,6-dihydropyrrolo(1,2-C)(1,3)benzodiazepin-5-one

C18H13N3O (287.1059)


   

2,4-Diethyl-4,4A-dihydro-1H-(1,3,5)triazino(1,2-A)quinoline-1,3,6(2H,5H)-trione

2,4-Diethyl-4,4A-dihydro-1H-(1,3,5)triazino(1,2-A)quinoline-1,3,6(2H,5H)-trione

C15H17N3O3 (287.127)


   

(S)-Norlaudanosoline

(S)-Norlaudanosoline

C16H17NO4 (287.1158)


   

Gabazine

Gabazine

C15H17N3O3 (287.127)


D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018756 - GABA Antagonists

   

Volkenin

Volkenin

C12H17NO7 (287.1005)


A cyanogenic glycoside that is (4R)-4-hydroxycyclopent-2-ene-1-carbonitrile attached to a beta-D-glucopyranosyloxy at position 1.

   
   

chlorproguanil

chlorproguanil

C11H15Cl2N5 (287.0704)


D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent D007004 - Hypoglycemic Agents > D001645 - Biguanides

   

sulmazole

sulmazole

C14H13N3O2S (287.0728)


C78274 - Agent Affecting Cardiovascular System > C78322 - Cardiotonic Agent D004791 - Enzyme Inhibitors > D010726 - Phosphodiesterase Inhibitors D020011 - Protective Agents > D002316 - Cardiotonic Agents D002317 - Cardiovascular Agents

   

Isomazole

Isomazole

C14H13N3O2S (287.0728)


C78274 - Agent Affecting Cardiovascular System > C78322 - Cardiotonic Agent D004791 - Enzyme Inhibitors > D010726 - Phosphodiesterase Inhibitors D020011 - Protective Agents > D002316 - Cardiotonic Agents D002317 - Cardiovascular Agents

   

(2E)-hexenedioylcarnitine

(2E)-hexenedioylcarnitine

C13H21NO6 (287.1369)


   

2-[6-(methoxymethyl)-4-oxo-1H-pyrimidin-2-yl]-1-(4-methylphenyl)guanidine

2-[6-(methoxymethyl)-4-oxo-1H-pyrimidin-2-yl]-1-(4-methylphenyl)guanidine

C14H17N5O2 (287.1382)


   

6,7,4-Trihydroxy-5-methoxy-flavylium

6,7,4-Trihydroxy-5-methoxy-flavylium

C16H15O5+ (287.0919)


   

ascr#13(1-)

ascr#13(1-)

C14H23O6 (287.1495)


Conjugate base of ascr#13

   
   

oscr#13(1-)

oscr#13(1-)

C14H23O6 (287.1495)


A hydroxy fatty acid ascaroside anion that is the conjugate base of oscr#13, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

tenofovir (anhydrous)

tenofovir (anhydrous)

C9H14N5O4P (287.0783)


A member of the class of phosphonic acids that is methylphosphonic acid in which one of the methyl hydrogens is replaced by a [(2R)-1-(6-amino-9H-purin-9-yl)propan-2-yl]oxy group. An inhibitor of HIV-1 reverse transcriptase, the bis(isopropyloxycarbonyloxymethyl) ester (disoproxil ester) prodrug is used as the fumaric acid salt in combination therapy for the treatment of HIV infection.

   

cytosylglucuronic acid

cytosylglucuronic acid

C10H13N3O7 (287.0753)


An N-glycosyl compound that is cytosine in which the proton at position 1 is replaced by a beta-D-glucuronosyl residue.

   

O-[(2E)-hexenedioyl]carnitine

O-[(2E)-hexenedioyl]carnitine

C13H21NO6 (287.1369)


An O-acylcarnitine having (2E)-hexenedioyl as the acyl substituent.

   
   
   

Cyclo(Thr-Trp)

Cyclo(Thr-Trp)

C15H17N3O3 (287.127)


   
   

4-hydroxy-3-(1-{[2-(4-hydroxyphenyl)ethyl]imino}ethyl)-6-methylpyran-2-one

4-hydroxy-3-(1-{[2-(4-hydroxyphenyl)ethyl]imino}ethyl)-6-methylpyran-2-one

C16H17NO4 (287.1158)


   

(3r)-6-oxo-1-(3-phenylpropanoyl)-2,3-dihydropyridin-3-yl acetate

(3r)-6-oxo-1-(3-phenylpropanoyl)-2,3-dihydropyridin-3-yl acetate

C16H17NO4 (287.1158)


   

(1r,4s)-4-hydroxy-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}cyclopent-2-ene-1-carbonitrile

(1r,4s)-4-hydroxy-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}cyclopent-2-ene-1-carbonitrile

C12H17NO7 (287.1005)


   

8-hydroxy-7-methoxy-2,2,6-trimethylpyrano[3,2-c]quinolin-5-one

8-hydroxy-7-methoxy-2,2,6-trimethylpyrano[3,2-c]quinolin-5-one

C16H17NO4 (287.1158)


   

(1s,17s,18s,19r)-5,7-dioxa-12-azapentacyclo[10.6.1.0²,¹⁰.0⁴,⁸.0¹⁵,¹⁹]nonadeca-2,4(8),9,15-tetraene-17,18-diol

(1s,17s,18s,19r)-5,7-dioxa-12-azapentacyclo[10.6.1.0²,¹⁰.0⁴,⁸.0¹⁵,¹⁹]nonadeca-2,4(8),9,15-tetraene-17,18-diol

C16H17NO4 (287.1158)


   

2-{[hydroxy(2-hydroxyphenyl)methylidene]amino}-4-methoxybenzoic acid

2-{[hydroxy(2-hydroxyphenyl)methylidene]amino}-4-methoxybenzoic acid

C15H13NO5 (287.0794)


   

(2e)-3-(4-hydroxy-3-methoxyphenyl)-n-[2-(3h-imidazol-4-yl)ethyl]prop-2-enimidic acid

(2e)-3-(4-hydroxy-3-methoxyphenyl)-n-[2-(3h-imidazol-4-yl)ethyl]prop-2-enimidic acid

C15H17N3O3 (287.127)


   

7-hydroxy-8-methoxy-2-methyl-5h-chromeno[4,3-b]pyridine-10-carboxylic acid

7-hydroxy-8-methoxy-2-methyl-5h-chromeno[4,3-b]pyridine-10-carboxylic acid

C15H13NO5 (287.0794)


   

(1s,7s,16r)-16-methoxy-5-oxa-10-azatetracyclo[8.7.0.0¹,¹³.0²,⁷]heptadeca-2,12,14-triene-4,11-dione

(1s,7s,16r)-16-methoxy-5-oxa-10-azatetracyclo[8.7.0.0¹,¹³.0²,⁷]heptadeca-2,12,14-triene-4,11-dione

C16H17NO4 (287.1158)


   

1-[(2e)-3-(3,4-dimethoxyphenyl)prop-2-enoyl]-5,6-dihydropyridin-2-one

1-[(2e)-3-(3,4-dimethoxyphenyl)prop-2-enoyl]-5,6-dihydropyridin-2-one

C16H17NO4 (287.1158)


   

(3z)-3-(1-{[2-(4-hydroxyphenyl)ethyl]amino}ethylidene)-6-methylpyran-2,4-dione

(3z)-3-(1-{[2-(4-hydroxyphenyl)ethyl]amino}ethylidene)-6-methylpyran-2,4-dione

C16H17NO4 (287.1158)


   

5,7,20,21-tetraoxa-14-azahexacyclo[16.2.1.0²,¹⁰.0⁴,⁸.0¹¹,¹⁵.0¹¹,¹⁹]henicosa-2(10),3,8-triene

5,7,20,21-tetraoxa-14-azahexacyclo[16.2.1.0²,¹⁰.0⁴,⁸.0¹¹,¹⁵.0¹¹,¹⁹]henicosa-2(10),3,8-triene

C16H17NO4 (287.1158)


   

n-[1-(4-methoxy-6-oxopyran-2-yl)-2-phenylethyl]ethanimidic acid

n-[1-(4-methoxy-6-oxopyran-2-yl)-2-phenylethyl]ethanimidic acid

C16H17NO4 (287.1158)


   

(1r,13s,15s,18r)-5,7-dioxa-12-azapentacyclo[10.6.1.0²,¹⁰.0⁴,⁸.0¹³,¹⁸]nonadeca-2,4(8),9,16-tetraene-15,18-diol

(1r,13s,15s,18r)-5,7-dioxa-12-azapentacyclo[10.6.1.0²,¹⁰.0⁴,⁸.0¹³,¹⁸]nonadeca-2,4(8),9,16-tetraene-15,18-diol

C16H17NO4 (287.1158)


   

n-{2-hydroxy-6-[(3-methylbutanoyl)oxy]-hexahydrofuro[3,2-b]furan-3-yl}ethanimidic acid

n-{2-hydroxy-6-[(3-methylbutanoyl)oxy]-hexahydrofuro[3,2-b]furan-3-yl}ethanimidic acid

C13H21NO6 (287.1369)


   

(1s,7r,16r)-16-methoxy-5-oxa-10-azatetracyclo[8.7.0.0¹,¹³.0²,⁷]heptadeca-2,12,14-triene-4,11-dione

(1s,7r,16r)-16-methoxy-5-oxa-10-azatetracyclo[8.7.0.0¹,¹³.0²,⁷]heptadeca-2,12,14-triene-4,11-dione

C16H17NO4 (287.1158)


   

16-methoxy-5-oxa-10-azatetracyclo[8.7.0.0¹,¹³.0²,⁷]heptadeca-2(7),12,14-triene-4,9-dione

16-methoxy-5-oxa-10-azatetracyclo[8.7.0.0¹,¹³.0²,⁷]heptadeca-2(7),12,14-triene-4,9-dione

C16H17NO4 (287.1158)


   

16-methoxy-5-oxa-10-azatetracyclo[8.7.0.0¹,¹³.0²,⁷]heptadeca-2,12,14-triene-4,11-dione

16-methoxy-5-oxa-10-azatetracyclo[8.7.0.0¹,¹³.0²,⁷]heptadeca-2,12,14-triene-4,11-dione

C16H17NO4 (287.1158)


   

5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9,16-tetraene-15,18-diol

5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9,16-tetraene-15,18-diol

C16H17NO4 (287.1158)


   

(2s)-2-{[(2s)-2-amino-1-hydroxypropylidene]amino}-3-hydroxy-3-[(3r)-7-oxo-4-oxa-1-azabicyclo[3.2.0]heptan-3-yl]propanoic acid

(2s)-2-{[(2s)-2-amino-1-hydroxypropylidene]amino}-3-hydroxy-3-[(3r)-7-oxo-4-oxa-1-azabicyclo[3.2.0]heptan-3-yl]propanoic acid

C11H17N3O6 (287.1117)


   

(1s,16r)-16-methoxy-5-oxa-10-azatetracyclo[8.7.0.0¹,¹³.0²,⁷]heptadeca-2(7),12,14-triene-4,11-dione

(1s,16r)-16-methoxy-5-oxa-10-azatetracyclo[8.7.0.0¹,¹³.0²,⁷]heptadeca-2(7),12,14-triene-4,11-dione

C16H17NO4 (287.1158)


   

16-methoxy-5-oxa-10-azatetracyclo[8.7.0.0¹,¹³.0²,⁷]heptadeca-2,12,14-triene-4,9-dione

16-methoxy-5-oxa-10-azatetracyclo[8.7.0.0¹,¹³.0²,⁷]heptadeca-2,12,14-triene-4,9-dione

C16H17NO4 (287.1158)


   

(2s,3s,4s,5r,6r)-3,4,5-trihydroxy-6-(2-hydroxy-4-iminopyrimidin-1-yl)oxane-2-carboxylic acid

(2s,3s,4s,5r,6r)-3,4,5-trihydroxy-6-(2-hydroxy-4-iminopyrimidin-1-yl)oxane-2-carboxylic acid

C10H13N3O7 (287.0753)


   

(1r,13s,15r,18s)-5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9,16-tetraene-15,18-diol

(1r,13s,15r,18s)-5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9,16-tetraene-15,18-diol

C16H17NO4 (287.1158)


   

(+)-11-hydroxyvittatine

NA

C16H17NO4 (287.1158)


{"Ingredient_id": "HBIN000458","Ingredient_name": "(+)-11-hydroxyvittatine","Alias": "NA","Ingredient_formula": "C16H17NO4","Ingredient_Smile": "C1C(C=CC23C1N(CC2O)CC4=CC5=C(C=C34)OCO5)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10825","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

2-benzamidobenzoic acid; 2',4-dihydroxy,me ester

NA

C15H13NO5 (287.0794)


{"Ingredient_id": "HBIN005344","Ingredient_name": "2-benzamidobenzoic acid; 2',4-dihydroxy,me ester","Alias": "NA","Ingredient_formula": "C15H13NO5","Ingredient_Smile": "NA","Ingredient_weight": "287.27","OB_score": "NA","CAS_id": "93289-91-9","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "8693","PubChem_id": "NA","DrugBank_id": "NA"}

   

2-benzamidobenzoic acid; 2'-hydroxy,4-methoxy

NA

C15H13NO5 (287.0794)


{"Ingredient_id": "HBIN005346","Ingredient_name": "2-benzamidobenzoic acid; 2'-hydroxy,4-methoxy","Alias": "NA","Ingredient_formula": "C15H13NO5","Ingredient_Smile": "NA","Ingredient_weight": "287.27","OB_score": "NA","CAS_id": "93289-90-8","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "8691","PubChem_id": "NA","DrugBank_id": "NA"}

   

amino[3,4-dihydroxy-5-(4-hydroxy-2-oxopyrimidin-1-yl)oxolan-2-yl]acetic acid

amino[3,4-dihydroxy-5-(4-hydroxy-2-oxopyrimidin-1-yl)oxolan-2-yl]acetic acid

C10H13N3O7 (287.0753)


   

(4as,7s)-6,7-dihydroxy-2-(4-hydroxyphenyl)-5-methoxy-4a,7-dihydro-1λ⁴-chromen-1-ylium

(4as,7s)-6,7-dihydroxy-2-(4-hydroxyphenyl)-5-methoxy-4a,7-dihydro-1λ⁴-chromen-1-ylium

[C16H15O5]+ (287.0919)


   

5,7,17-trioxa-12-azahexacyclo[10.6.2.0¹,¹³.0²,¹⁰.0⁴,⁸.0¹⁶,¹⁸]icosa-2,4(8),9-trien-15-ol

5,7,17-trioxa-12-azahexacyclo[10.6.2.0¹,¹³.0²,¹⁰.0⁴,⁸.0¹⁶,¹⁸]icosa-2,4(8),9-trien-15-ol

C16H17NO4 (287.1158)


   

(1s,13r,15r,16s,18r)-5,7,17-trioxa-12-azahexacyclo[10.6.2.0¹,¹³.0²,¹⁰.0⁴,⁸.0¹⁶,¹⁸]icosa-2,4(8),9-trien-15-ol

(1s,13r,15r,16s,18r)-5,7,17-trioxa-12-azahexacyclo[10.6.2.0¹,¹³.0²,¹⁰.0⁴,⁸.0¹⁶,¹⁸]icosa-2,4(8),9-trien-15-ol

C16H17NO4 (287.1158)


   

(1r,4s)-4-hydroxy-1-{[(2s,3r,4s,5s,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}cyclopent-2-ene-1-carbonitrile

(1r,4s)-4-hydroxy-1-{[(2s,3r,4s,5s,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}cyclopent-2-ene-1-carbonitrile

C12H17NO7 (287.1005)


   

(1s,17s,18r,19r)-5,7-dioxa-12-azapentacyclo[10.6.1.0²,¹⁰.0⁴,⁸.0¹⁵,¹⁹]nonadeca-2,4(8),9,15-tetraene-17,18-diol

(1s,17s,18r,19r)-5,7-dioxa-12-azapentacyclo[10.6.1.0²,¹⁰.0⁴,⁸.0¹⁵,¹⁹]nonadeca-2,4(8),9,15-tetraene-17,18-diol

C16H17NO4 (287.1158)


   

(1s,17r,18s,19s)-5,7-dioxa-12-azapentacyclo[10.6.1.0²,¹⁰.0⁴,⁸.0¹⁵,¹⁹]nonadeca-2,4(8),9,15-tetraene-17,18-diol

(1s,17r,18s,19s)-5,7-dioxa-12-azapentacyclo[10.6.1.0²,¹⁰.0⁴,⁸.0¹⁵,¹⁹]nonadeca-2,4(8),9,15-tetraene-17,18-diol

C16H17NO4 (287.1158)


   

(1s,11r,15r)-5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9,16-tetraene-11,15-diol

(1s,11r,15r)-5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9,16-tetraene-11,15-diol

C16H17NO4 (287.1158)


   

(1s,11r,13r,15r)-5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9,16-tetraene-11,15-diol

(1s,11r,13r,15r)-5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9,16-tetraene-11,15-diol

C16H17NO4 (287.1158)


   

(1s,11s,13r,15r)-5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9,16-tetraene-11,15-diol

(1s,11s,13r,15r)-5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9,16-tetraene-11,15-diol

C16H17NO4 (287.1158)


   

(1s,13s,15r,18s)-5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9,16-tetraene-15,18-diol

(1s,13s,15r,18s)-5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9,16-tetraene-15,18-diol

C16H17NO4 (287.1158)


   

6-{[2-(3h-imidazol-4-yl)ethyl](methyl)amino}pteridine-2,4-diol

6-{[2-(3h-imidazol-4-yl)ethyl](methyl)amino}pteridine-2,4-diol

C12H13N7O2 (287.1131)


   

1,6-dihydroxy-3,5-dimethoxy-10h-acridin-9-one

1,6-dihydroxy-3,5-dimethoxy-10h-acridin-9-one

C15H13NO5 (287.0794)


   

(2s)-4-({4-methoxyfuro[2,3-b]quinolin-7-yl}oxy)butan-2-ol

(2s)-4-({4-methoxyfuro[2,3-b]quinolin-7-yl}oxy)butan-2-ol

C16H17NO4 (287.1158)


   

1,5-dihydroxy-3,4-dimethoxy-10h-acridin-9-one

1,5-dihydroxy-3,4-dimethoxy-10h-acridin-9-one

C15H13NO5 (287.0794)


   

13-isopropyl-16-methyl-3,5,14-trioxa-16-azatetracyclo[7.7.0.0²,⁶.0¹¹,¹⁵]hexadeca-1,6,8,11(15)-tetraen-10-one

13-isopropyl-16-methyl-3,5,14-trioxa-16-azatetracyclo[7.7.0.0²,⁶.0¹¹,¹⁵]hexadeca-1,6,8,11(15)-tetraen-10-one

C16H17NO4 (287.1158)


   

1-[3-(3,4-dimethoxyphenyl)prop-2-enoyl]-5,6-dihydropyridin-2-one

1-[3-(3,4-dimethoxyphenyl)prop-2-enoyl]-5,6-dihydropyridin-2-one

C16H17NO4 (287.1158)


   

(2s)-2-{[(2s)-2-amino-1-hydroxypropylidene]amino}-3-hydroxy-3-[(3r,5s)-7-oxo-4-oxa-1-azabicyclo[3.2.0]heptan-3-yl]propanoic acid

(2s)-2-{[(2s)-2-amino-1-hydroxypropylidene]amino}-3-hydroxy-3-[(3r,5s)-7-oxo-4-oxa-1-azabicyclo[3.2.0]heptan-3-yl]propanoic acid

C11H17N3O6 (287.1117)


   

(1s,13s,15s,18r)-5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9,16-tetraene-15,18-diol

(1s,13s,15s,18r)-5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9,16-tetraene-15,18-diol

C16H17NO4 (287.1158)


   

n-[(1s)-1-(4-methoxy-6-oxopyran-2-yl)-2-phenylethyl]ethanimidic acid

n-[(1s)-1-(4-methoxy-6-oxopyran-2-yl)-2-phenylethyl]ethanimidic acid

C16H17NO4 (287.1158)


   

(1s,13r,15s,16s)-5,7-dioxa-12-azapentacyclo[10.6.1.0²,¹⁰.0⁴,⁸.0¹³,¹⁸]nonadeca-2,4(8),9,17-tetraene-15,16-diol

(1s,13r,15s,16s)-5,7-dioxa-12-azapentacyclo[10.6.1.0²,¹⁰.0⁴,⁸.0¹³,¹⁸]nonadeca-2,4(8),9,17-tetraene-15,16-diol

C16H17NO4 (287.1158)


   

(1s,11r,13s,15r)-5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9,16-tetraene-11,15-diol

(1s,11r,13s,15r)-5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9,16-tetraene-11,15-diol

C16H17NO4 (287.1158)


   

(1s,13s,15s,18s)-5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9,16-tetraene-15,18-diol

(1s,13s,15s,18s)-5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9,16-tetraene-15,18-diol

C16H17NO4 (287.1158)


   

1-(2-hydroxy-4,8-dimethoxyquinolin-3-yl)-3-methylbut-3-en-2-one

1-(2-hydroxy-4,8-dimethoxyquinolin-3-yl)-3-methylbut-3-en-2-one

C16H17NO4 (287.1158)


   

5,7-dioxa-12-azapentacyclo[10.6.1.0²,¹⁰.0⁴,⁸.0¹³,¹⁸]nonadeca-2,4(8),9,17-tetraene-15,16-diol

5,7-dioxa-12-azapentacyclo[10.6.1.0²,¹⁰.0⁴,⁸.0¹³,¹⁸]nonadeca-2,4(8),9,17-tetraene-15,16-diol

C16H17NO4 (287.1158)


   

2-hydroxy-6-({[2-(hydroxymethyl)phenyl]methyl}imino)-2,5-dimethylcyclohex-4-ene-1,3-dione

2-hydroxy-6-({[2-(hydroxymethyl)phenyl]methyl}imino)-2,5-dimethylcyclohex-4-ene-1,3-dione

C16H17NO4 (287.1158)


   

(1s,13r,15s,18s)-5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9,16-tetraene-15,18-diol

(1s,13r,15s,18s)-5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9,16-tetraene-15,18-diol

C16H17NO4 (287.1158)


   

(2s,3s)-2-{[(2s)-2-amino-1-hydroxypropylidene]amino}-3-hydroxy-3-[(3s,5s)-7-oxo-4-oxa-1-azabicyclo[3.2.0]heptan-3-yl]propanoic acid

(2s,3s)-2-{[(2s)-2-amino-1-hydroxypropylidene]amino}-3-hydroxy-3-[(3s,5s)-7-oxo-4-oxa-1-azabicyclo[3.2.0]heptan-3-yl]propanoic acid

C11H17N3O6 (287.1117)


   

7-amino-6,8,9-trihydroxy-4-methoxy-3-methylphenalen-1-one

7-amino-6,8,9-trihydroxy-4-methoxy-3-methylphenalen-1-one

C15H13NO5 (287.0794)


   

3,4-dihydroxy-n-(1-hydroxy-3-phenylpropan-2-yl)benzenecarboximidic acid

3,4-dihydroxy-n-(1-hydroxy-3-phenylpropan-2-yl)benzenecarboximidic acid

C16H17NO4 (287.1158)


   

(3r,6r)-3-(1-hydroxyethyl)-6-(1h-indol-3-ylmethyl)-3,6-dihydropyrazine-2,5-diol

(3r,6r)-3-(1-hydroxyethyl)-6-(1h-indol-3-ylmethyl)-3,6-dihydropyrazine-2,5-diol

C15H17N3O3 (287.127)


   

epitetraphyllin b

epitetraphyllin b

C12H17NO7 (287.1005)


   

n-[(2r,3r,3ar,6r,6as)-2-hydroxy-6-[(3-methylbutanoyl)oxy]-hexahydrofuro[3,2-b]furan-3-yl]ethanimidic acid

n-[(2r,3r,3ar,6r,6as)-2-hydroxy-6-[(3-methylbutanoyl)oxy]-hexahydrofuro[3,2-b]furan-3-yl]ethanimidic acid

C13H21NO6 (287.1369)


   
   

(1s,4s)-4-hydroxy-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}cyclopent-2-ene-1-carbonitrile

(1s,4s)-4-hydroxy-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}cyclopent-2-ene-1-carbonitrile

C12H17NO7 (287.1005)


   

14-methoxy-13-methyl-2-oxa-9-azatricyclo[9.4.0.0³,⁸]pentadeca-1(11),3,5,7,9,12,14-heptaene-5,10,12-triol

14-methoxy-13-methyl-2-oxa-9-azatricyclo[9.4.0.0³,⁸]pentadeca-1(11),3,5,7,9,12,14-heptaene-5,10,12-triol

C15H13NO5 (287.0794)


   

1,3,5-trihydroxy-2-methoxy-10-methylacridin-9-one

1,3,5-trihydroxy-2-methoxy-10-methylacridin-9-one

C15H13NO5 (287.0794)


   

3,13,17-triazapentacyclo[11.9.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]docosa-2(10),4,6,8,15,17,19,21-octaene

3,13,17-triazapentacyclo[11.9.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]docosa-2(10),4,6,8,15,17,19,21-octaene

C19H17N3 (287.1422)


   

5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9,16-tetraene-11,15-diol

5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9,16-tetraene-11,15-diol

C16H17NO4 (287.1158)


   

(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl 1-methylpyrrole-2-carboxylate

(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl 1-methylpyrrole-2-carboxylate

C12H17NO7 (287.1005)


   

(1s)-4-hydroxy-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}cyclopent-2-ene-1-carbonitrile

(1s)-4-hydroxy-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}cyclopent-2-ene-1-carbonitrile

C12H17NO7 (287.1005)


   

(1s,16r)-16-methoxy-5-oxa-10-azatetracyclo[8.7.0.0¹,¹³.0²,⁷]heptadeca-2(7),12,14-triene-4,9-dione

(1s,16r)-16-methoxy-5-oxa-10-azatetracyclo[8.7.0.0¹,¹³.0²,⁷]heptadeca-2(7),12,14-triene-4,9-dione

C16H17NO4 (287.1158)


   

3,4,5-trihydroxy-6-(2-hydroxy-4-iminopyrimidin-1-yl)oxane-2-carboxylic acid

3,4,5-trihydroxy-6-(2-hydroxy-4-iminopyrimidin-1-yl)oxane-2-carboxylic acid

C10H13N3O7 (287.0753)


   

(1s,13r,14s,15s)-6,8-dioxa-12-azapentacyclo[10.6.1.0²,¹⁰.0⁵,⁹.0¹³,¹⁸]nonadeca-2(10),3,5(9),17-tetraene-14,15-diol

(1s,13r,14s,15s)-6,8-dioxa-12-azapentacyclo[10.6.1.0²,¹⁰.0⁵,⁹.0¹³,¹⁸]nonadeca-2(10),3,5(9),17-tetraene-14,15-diol

C16H17NO4 (287.1158)


   

(1s,11s,15r)-5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9,16-tetraene-11,15-diol

(1s,11s,15r)-5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9,16-tetraene-11,15-diol

C16H17NO4 (287.1158)


   

5,7-dioxa-12-azapentacyclo[10.6.1.0²,¹⁰.0⁴,⁸.0¹³,¹⁸]nonadeca-2,4(8),9,17-tetraene-14,15-diol

5,7-dioxa-12-azapentacyclo[10.6.1.0²,¹⁰.0⁴,⁸.0¹³,¹⁸]nonadeca-2,4(8),9,17-tetraene-14,15-diol

C16H17NO4 (287.1158)


   

n-[(3r,3ar,6r,6as)-2-hydroxy-6-[(3-methylbutanoyl)oxy]-hexahydrofuro[3,2-b]furan-3-yl]ethanimidic acid

n-[(3r,3ar,6r,6as)-2-hydroxy-6-[(3-methylbutanoyl)oxy]-hexahydrofuro[3,2-b]furan-3-yl]ethanimidic acid

C13H21NO6 (287.1369)


   

2,5,7,13-tetraoxa-18-azahexacyclo[12.7.0.0³,¹¹.0⁴,⁸.0¹⁰,¹⁵.0¹⁵,¹⁹]henicosa-3,8,10-triene

2,5,7,13-tetraoxa-18-azahexacyclo[12.7.0.0³,¹¹.0⁴,⁸.0¹⁰,¹⁵.0¹⁵,¹⁹]henicosa-3,8,10-triene

C16H17NO4 (287.1158)


   

(1r,13r,15s,18r)-5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9,16-tetraene-15,18-diol

(1r,13r,15s,18r)-5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9,16-tetraene-15,18-diol

C16H17NO4 (287.1158)


   

(1s,4r)-4-hydroxy-1-{[(2r,3s,4r,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}cyclopent-2-ene-1-carbonitrile

(1s,4r)-4-hydroxy-1-{[(2r,3s,4r,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}cyclopent-2-ene-1-carbonitrile

C12H17NO7 (287.1005)


   

5,7-dioxa-12-azapentacyclo[10.6.1.0²,¹⁰.0⁴,⁸.0¹³,¹⁸]nonadeca-2,4(8),9,16-tetraene-15,18-diol

5,7-dioxa-12-azapentacyclo[10.6.1.0²,¹⁰.0⁴,⁸.0¹³,¹⁸]nonadeca-2,4(8),9,16-tetraene-15,18-diol

C16H17NO4 (287.1158)


   

3-[(2-{[ethoxy(hydroxy)methylidene]amino}ethoxy(hydroxy)phosphoryl)oxy]propane-1,2-diol

3-[(2-{[ethoxy(hydroxy)methylidene]amino}ethoxy(hydroxy)phosphoryl)oxy]propane-1,2-diol

C8H18NO8P (287.077)


   

5,17-dimethyl-3,8-dioxa-10-azapentacyclo[10.8.0.0²,⁶.0⁷,¹¹.0¹³,¹⁸]icosa-1,4,6,9,11,13(18),14,16,19-nonaene

5,17-dimethyl-3,8-dioxa-10-azapentacyclo[10.8.0.0²,⁶.0⁷,¹¹.0¹³,¹⁸]icosa-1,4,6,9,11,13(18),14,16,19-nonaene

C19H13NO2 (287.0946)


   

2,6-dihydroxy-n-[2-(4-methoxyphenyl)ethyl]benzenecarboximidic acid

2,6-dihydroxy-n-[2-(4-methoxyphenyl)ethyl]benzenecarboximidic acid

C16H17NO4 (287.1158)


   

(1s,13r,15r,18s)-5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9,16-tetraene-15,18-diol

(1s,13r,15r,18s)-5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9,16-tetraene-15,18-diol

C16H17NO4 (287.1158)


   

4-amino-7-[(2r,3r,4s)-3-hydroxy-4-methoxy-5-methylideneoxolan-2-yl]pyrrolo[2,3-d]pyrimidine-5-carbonitrile

4-amino-7-[(2r,3r,4s)-3-hydroxy-4-methoxy-5-methylideneoxolan-2-yl]pyrrolo[2,3-d]pyrimidine-5-carbonitrile

C13H13N5O3 (287.1018)


   

(1r,4s)-4-hydroxy-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}cyclopent-2-ene-1-carbonitrile

(1r,4s)-4-hydroxy-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}cyclopent-2-ene-1-carbonitrile

C12H17NO7 (287.1005)


   

3,4-dihydroxy-n-[(2s)-1-hydroxy-3-phenylpropan-2-yl]benzenecarboximidic acid

3,4-dihydroxy-n-[(2s)-1-hydroxy-3-phenylpropan-2-yl]benzenecarboximidic acid

C16H17NO4 (287.1158)


   

5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9,14-tetraene-16,17-diol

5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9,14-tetraene-16,17-diol

C16H17NO4 (287.1158)


   

3-methoxy-2-methyl-1-phenyl-9h-carbazole

3-methoxy-2-methyl-1-phenyl-9h-carbazole

C20H17NO (287.131)


   

(1s,13r,16s,17r)-5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9,14-tetraene-16,17-diol

(1s,13r,16s,17r)-5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9,14-tetraene-16,17-diol

C16H17NO4 (287.1158)


   

6-methoxy-7-(3-methylbut-2-en-1-yl)-2h-[1,3]dioxolo[4,5-h]quinolin-8-ol

6-methoxy-7-(3-methylbut-2-en-1-yl)-2h-[1,3]dioxolo[4,5-h]quinolin-8-ol

C16H17NO4 (287.1158)


   

5,17-dimethyl-3,10-dioxa-8-azapentacyclo[10.8.0.0²,⁶.0⁷,¹¹.0¹³,¹⁸]icosa-1,4,6,8,11,13(18),14,16,19-nonaene

5,17-dimethyl-3,10-dioxa-8-azapentacyclo[10.8.0.0²,⁶.0⁷,¹¹.0¹³,¹⁸]icosa-1,4,6,8,11,13(18),14,16,19-nonaene

C19H13NO2 (287.0946)


   

(1s)-3,13,18-triazapentacyclo[11.9.0.0²,¹⁰.0⁴,⁹.0¹⁶,²¹]docosa-2(10),4,6,8,14,16,18,20-octaene

(1s)-3,13,18-triazapentacyclo[11.9.0.0²,¹⁰.0⁴,⁹.0¹⁶,²¹]docosa-2(10),4,6,8,14,16,18,20-octaene

C19H17N3 (287.1422)


   

(2e)-1-(3,4-dihydro-2h-pyridin-1-yl)-3-(7-methoxy-2h-1,3-benzodioxol-5-yl)prop-2-en-1-one

(2e)-1-(3,4-dihydro-2h-pyridin-1-yl)-3-(7-methoxy-2h-1,3-benzodioxol-5-yl)prop-2-en-1-one

C16H17NO4 (287.1158)


   

(2r)-2-hydroxy-6-({[2-(hydroxymethyl)phenyl]methyl}imino)-2,5-dimethylcyclohex-4-ene-1,3-dione

(2r)-2-hydroxy-6-({[2-(hydroxymethyl)phenyl]methyl}imino)-2,5-dimethylcyclohex-4-ene-1,3-dione

C16H17NO4 (287.1158)


   

3,13,17-triazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-1(21),2(10),4,6,8,15,17,19-octaen-14-one

3,13,17-triazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-1(21),2(10),4,6,8,15,17,19-octaen-14-one

C18H13N3O (287.1059)


   

n-[(3s,3ar,6r,6as)-2-hydroxy-6-[(3-methylbutanoyl)oxy]-hexahydrofuro[3,2-b]furan-3-yl]ethanimidic acid

n-[(3s,3ar,6r,6as)-2-hydroxy-6-[(3-methylbutanoyl)oxy]-hexahydrofuro[3,2-b]furan-3-yl]ethanimidic acid

C13H21NO6 (287.1369)


   

(2r)-3-[(2-{[ethoxy(hydroxy)methylidene]amino}ethoxy(hydroxy)phosphoryl)oxy]propane-1,2-diol

(2r)-3-[(2-{[ethoxy(hydroxy)methylidene]amino}ethoxy(hydroxy)phosphoryl)oxy]propane-1,2-diol

C8H18NO8P (287.077)


   

16-methoxy-5-oxa-10-azatetracyclo[8.7.0.0¹,¹³.0²,⁷]heptadeca-2(7),12,14-triene-4,11-dione

16-methoxy-5-oxa-10-azatetracyclo[8.7.0.0¹,¹³.0²,⁷]heptadeca-2(7),12,14-triene-4,11-dione

C16H17NO4 (287.1158)


   

(1r,4r)-4-hydroxy-1-{[(2s,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}cyclopent-2-ene-1-carbonitrile

(1r,4r)-4-hydroxy-1-{[(2s,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}cyclopent-2-ene-1-carbonitrile

C12H17NO7 (287.1005)


   

1,5-dihydroxy-4-methoxy-3,10-dimethyl-8a,10a-dihydroacridin-9-one

1,5-dihydroxy-4-methoxy-3,10-dimethyl-8a,10a-dihydroacridin-9-one

C16H17NO4 (287.1158)


   

(1r,11s,15r,18r,19s)-5,7,20,21-tetraoxa-14-azahexacyclo[16.2.1.0²,¹⁰.0⁴,⁸.0¹¹,¹⁵.0¹¹,¹⁹]henicosa-2(10),3,8-triene

(1r,11s,15r,18r,19s)-5,7,20,21-tetraoxa-14-azahexacyclo[16.2.1.0²,¹⁰.0⁴,⁸.0¹¹,¹⁵.0¹¹,¹⁹]henicosa-2(10),3,8-triene

C16H17NO4 (287.1158)


   

(1s,7r,16r)-16-methoxy-5-oxa-10-azatetracyclo[8.7.0.0¹,¹³.0²,⁷]heptadeca-2,12,14-triene-4,9-dione

(1s,7r,16r)-16-methoxy-5-oxa-10-azatetracyclo[8.7.0.0¹,¹³.0²,⁷]heptadeca-2,12,14-triene-4,9-dione

C16H17NO4 (287.1158)


   

n-[(2r,3s,3ar,6r,6as)-2-hydroxy-6-[(3-methylbutanoyl)oxy]-hexahydrofuro[3,2-b]furan-3-yl]ethanimidic acid

n-[(2r,3s,3ar,6r,6as)-2-hydroxy-6-[(3-methylbutanoyl)oxy]-hexahydrofuro[3,2-b]furan-3-yl]ethanimidic acid

C13H21NO6 (287.1369)